2013 July

Within the United Kingdom, data from England and Wales show that drug misuse was responsible for 10 percent of deaths from all causes for those aged 20-39 in 2011.

Heroin and morphine accounted for most of the deaths, but between 2010 and 2011 the number of deaths associated with these two drugs declined by 25 per cent, from 791 to 596. This decline might have been associated with the heroin “drought” experienced in the United Kingdom starting in 2010. However, over the same time period, the number of deaths related to the use of methadone, reportedly mixed with benzodiazepines and/or alcohol, increased by 37 per cent, from 355 to 486.

A similar situation was observed in Scotland, where there was a 19 per cent decline in the number of deaths involving heroin and morphine, from 254 in 2010 to 206 in 2011, with a simultaneous 58 per cent increase in the number of deaths associated with methadone, from 174 in 2010 to 275 deaths in 2011.

Across the United Kingdom, the involvement of multiple substances implicated in drug-related deaths, notably the use of opiates/opioid analgesics, benzodiazepines and alcohol, has been noted, highlighting the increased risk associated with polydrug use.

Source:  World Drug Report 2013  www.unodc.org  June 2013

Filed under: Effects of Drugs :

The overlap between substance problems and mental concerns, such as mood and behavior disorders, is large. If you have one, you’re more likely to find yourself with the other also.

For example:

* People with depression or anxiety are roughly twice as likely to have some kind of drug use disorder.1   * Research has found that more than 40 percent of people with bipolar disorder will have a substance use disorder during their lives.2

* The converse is also true. Among those who are seeking help for a substance use disorder, as many as 50 to 75 percent will also have anxiety, depression, or some other mental health issue.3

And here’s another common condition that’s also associated with a significantly increased risk of illicit drug use: ADHD. The relationship is quite high, and it begins in adolescence and continues into adulthood.

A 2011 study that followed kids and teens for 10 years found that those who were diagnosed with ADHD were 47 percent more likely to have a substance use disorder later in life than their peers without ADHD.4

So which condition causes the other? This question arises in my psychiatric practice regularly. In all likelihood, some causation is traveling in both directions. Drug use—especially during adolescence—increases the chances of various forms of mental illness. Given that drugs can harm normal brain development, the drug use likely causes mental illness to arise in people who were already vulnerable to developing it.1 On the other hand, some people with a mental health issue may use drugs to self-medicate symptoms.

In any particular person, discovering which caused which is often impossible. Knowing the order in which these problems became apparent can be informative. But it’s not enough to lead us to state with certainty that one caused the other, because we usually can’t know if the second problem would have arisen anyway.

Reassuring findings about ADHD meds This leads us to an important question about ADHD that concerns many parents. I have heard more than a few folks say something to the effect of: “Wait … psychiatrists and other doctors are putting kids with ADHD on stimulant drugs, which have enough kick that some people use them recreationally. Isn’t it possible that ADHD medications themselves put kids at higher risk of developing substance problems?

That’s a valid concern, given that nearly 3 million kids and teens were being treated with medication for ADHD in 2007.5 However, although some might worry that treating ADHD symptoms with psychostimulant medications would result in later illicit drug use, a number of studies over the years have concluded that there seems to be “no compelling evidence that stimulant treatment of children with ADHD leads to an increased risk for substance experimentation, use, dependence, or abuse by adulthood.”6

It’s even possible that treating ADHD with medications helps protect kids from later drug use. One 2008 study followed 114 children with ADHD for five years, until they were 16 years old on average. Ninety-four of them had been treated with stimulant medications. The researchers found no increased risk of substance use disorders linked to treatment with stimulant medications. In fact, they found that kids who took these medications were 73 percent less likely to have a substance use disorder.7

Thus, although it might make intuitive sense to be concerned that treating ADHD with stimulants is setting the child up for trouble with drugs down the line, research does not bear that out and, in fact, it suggests the opposite.

The best advice for someone with either a substance use problem or mental health disorder is to remain vigilant for the emergence of the other type of problem. Their interrelationship is complex and still being sorted out – and it’s a good idea to tell any doctor who’s treating you if you have either (or both) of these issues.

Source:  Published on March 27, 2013 by J. Wesley Boyd, M.D., Ph.D. in Almost Addicted

The number one reason youngsters give for not smoking or using drugs is fear of disappointing their parents. You can be a powerful influence. You can set clear expectations and limits. You can be a supporter who encourages them to pursue their dreams and goals.

Here are 7 ways you can protect your child from alcohol and other drugs:

1. Talk Often With Your Kids

Fact: Kids who learn a lot about the risks of alcohol and other drugs from their parents are up to 50% less likely to use.

* Have regular discussions from an early age, with consistent messages about the risks of alcohol and other drugs.

* Plan what you want to say for the appropriate age.

* Practice how you will respond to tough questions.

* Find teachable moments.

* Teach them how to turn down alcohol and other drugs. * Visit www.timetotalk.org for more helpful tips on how to talk with your kids.

2. Be Clear About Your Expectations

Fact: You can build trust with your child by having clear and consistent rules.

Tell them it is not okay to drink or do drugs because:

* It‘s against the law.

* You’re still growing and your brain is still developing. Alcohol and drugs can damage your memory, your ability to learn, and can permanently damage your brain.

* Doing drugs and drinking when you’re a teen makes you more likely to become addicted, and can lead to desperate measures including committing crimes.

* You are more likely to make a bad decision when you are drinking or getting high, such as getting in a car, getting in a fight, or having sex.

* Kids who drink are more likely to try other drugs.

3. Be a Role Model

Fact: Kids imitate adults.

* If you drink, do it in moderation, defined as “the consumption of up to one drink a day for women and up to two drinks a day for men.”

* Never drink and drive.

* Don’t use illegal drugs.

* Use prescription drugs properly.

* (Never say things like “I need a drink” – the message heard by teens is ‘a drink helps when you have a bad day, stress or problems !)

4. Be Involved In Your Kid’s Life

Fact: Kids are less likely to use drugs when they have relationships with caring adults.

* Listen to your child. Ask them about things they enjoy doing.

* Be empathetic about problems with friends.

* When your child seems angry or upset, start a conversation with an observation like “you seem sad” or “you seem stressed.”

* Have dinner together at least four times a week.

* Get to know your child’s friends and their parents.

* When your child is going to someone’s house, make sure an adult will be home.

* Encourage your child to call any time they feel uncomfortable.

5.  Establish Rules and Follow Through

Fact: Parents’ leniency is a bigger factor in teenage drug use than peer pressure.

* Talk to your child about rules at a calm time. Explain the rules, for example what time they must come home, and the consequence for breaking the rule.

* Build a trusting relationship with respect and consistency. Reward good behavior.

* Follow through with consequences. Uphold your rules and rules set by the school and community. If your child is punished for breaking a rule, help them understand why, and discuss what they can do differently in the future.

Here are some responses to common excuses and arguments:

* “You’re the only parent who won’t let me…” (I am sorry you feel that way, but that is the rule in this house.)

* “I didn’t know I was supposed to be home at… “ (You do now.)

* “It’s not mine, I was holding it for a friend… “ (You’re still responsible.)

* “I swear, it was the first time I tried it… “(Bad things can happen on the first time.)

* “That teacher/person in charge is out to get me…“ (That is irrelevant.)

* “Why don’t you trust me? … “ (Your trust bank account is low right now. Here’s what you can do to make a deposit.)

6. Encourage Your Child to Work Hard in School:

Fact: Kids who perform well in school are less likely to become involved with alcohol and drugs.

* Encourage improvements in grades and in good work.

* Make sure your teen has a quiet place to do homework.

* Coach your child on effective ways to ask teachers for help and advice.

 

7. Support Your Child’s Involvement in Outside Activities:

Fact: Kids who pursue their interests and dreams are less likely to try alcohol and drugs.

* Community Service – Volunteering and getting involved in the community give a sense of purpose, and expand your child’s awareness of the world.

* Sports– Keeping active in sports provides physical, mental and emotional benefits, and keeps kids from getting bored.

* Art, Drama and Music – Creative expression and friends with common interests can help a child develop a talent and increase self-confidence.

Filed under: Parents :

Recovery from alcohol and drug problems is a process of change through which an individual achieves abstinence and improved health, wellness and quality of life.

Guiding Principles

There are many pathways to recovery. Individuals are unique with specific needs, strengths, goals, health attitudes, behaviors and expectations for recovery. Recovery is a process of change that permits an individual to make healthy choices and improve the quality of his/her life.

Recovery is self-directed and empowering. The process of recovery leads individuals toward the highest level of autonomy of which they are capable. Through self-empowerment, individuals become optimistic about life goals.

Recovery involves a personal recognition of the need for change and transformation. The process of change can involve physical, emotional, intellectual and spiritual aspects of the person’s life.

Recovery is holistic. Recovery is a process through which one gradually achieves greater balance of mind, body and spirit in relation to other aspects of one’s life, including family, work and community.

Recovery has cultural dimensions. Each person’s recovery process is unique and impacted by cultural beliefs and traditions.

Recovery exists on a continuum of improved health and wellness. Recovery is not a linear process. It is based on continual growth and improved functioning.

Recovery emerges from hope and gratitude. Individuals in or seeking recovery often gain hope from those who share their search for or experience of recovery. They see that people can and do overcome the obstacles that confront them and they cultivate gratitude for the opportunities that each day of recovery offers.

Recovery involves a process of healing and self-redefinition. Recovery is a holistic healing process in which one develops a positive and meaningful sense of identity.

Recovery involves addressing discrimination and transcending shame and stigma. Recovery is a process by which people confront and strive to overcome stigma.

Recovery is supported by peers and allies. A common denominator in the recovery process is the presence and involvement of people who contribute hope and support and suggest strategies and resources for change.

Recovery involves (re)joining and (re)building a life in the community. Recovery involves a process of building or rebuilding what a person has lost or never had due to his/her condition and its consequences.

Recovery is a reality. It can, will, and does happen.

Source: Natl. Summit on Recovery, Conference Report – SAMHSA – September 2005  Published at www.drugfreeNH.org   

Filed under: Parents :

If you could get 70 percent of Americans addicted to your drugs and rake in $280 billion a year in the process, would you do it? If you could come up with a “pill for every problem” and charge Americans twice as much for those pills as people in other countries pay, would you do it? If you could make more money than you ever dreamed possible by turning the American people into the most doped up people in the history of the planet, would you do it? In America today, the number of people hooked on legal drugs absolutely dwarfs the number of people hooked on illegal drugs. And sadly, the number of people killed by legal drugs absolutely dwarfs the number of people killed by illegal drugs. But most Americans assume that if a drug is “legal” that it must be safe.  After all, the big pharmaceutical companies and the federal government would never allow us to take anything that would hurt us, right? Sadly, the truth is that they don’t really care about us. They don’t really care that prescription painkillers are some of the most addictive drugs on the entire planet and that they kill more Americans each year than heroin and cocaine combined. They don’t care that antidepressants are turning tens of millions of Americans into zombies and can significantly increase the chance of suicide (just look at the warning label). All the big pharmaceutical companies really care about is making as much money as they possibly can. The following are 20 signs that the pharmaceutical companies are running a $280 billion money making scam… #1   According to a study conducted by the Mayo Clinic, 70 percent of Americans are on at least one prescription drug. An astounding 20 percent of all Americans are on at least five prescription drugs. #2   According to the CDC, approximately 9 out of every 10 Americans that are at least 60 years of age say that they have taken at least one prescription drug within the last month. #3   The 11 largest pharmaceutical companies combined to rake in approximately $85,000,000,000 in profits in 2012. #4   During 2013, Americans will spend more than 280 billion dollars on prescription drugs. #5   According to Alternet, last year “11 of the 12 new-to-market drugs approved by the Food and Drug Administration were priced above $100,000 per-patient per-year”. #6   The CDC says that spending on prescription drugs more than doubledbetween 1999 and 2008. #7   Many prescription drugs cost about twice as much in the United States as they do in other countries. #8   One study found that more than 20 percent of all American adults are taking at least one drug for “psychiatric” or “behavioral” disorders. #9   The percentage of women taking antidepressants in America is higher than in any other country in the world. #10   Children in the United States are three times more likely to be prescribed antidepressants than children in Europe are. #11   A shocking Government Accountability Office report discovered that approximately one-third of all foster children in the United States are on at least one

psychiatric drug. In fact, the report found that many states seem to be doping up foster children as a matter of course. Just check out these stunning statistics… In Texas, foster children were 53 times more likely to be prescribed five or more psychiatric medications at the same time than non-foster children. In Massachusetts, they were 19 times more likely. In Michigan, the number was 15 times. It was 13 times in Oregon. And in Florida, foster children were nearly four times as likely to be given five or more psychotropic medications at the same time compared to non-foster children. #12   In 2010, the average teen in the U.S. was taking 1.2 central nervous system drugs. Those are the kinds of drugs which treat conditions such as ADHD and depression. #13   The total number of Americans taking antidepressants doubled between 1996 and 2005. #14   All of those antidepressants don’t seem to be working too well. The suicide rate for Americans between the ages of 35 and 64 rose by close to 30 percent between 1999 and 2010. The number of Americans that are killed by suicide now exceeds the number of Americans that die as a result of car accidents. #15   According to the National Household Survey on Drug Abuse, 36 millionAmericans have abused prescription drugs at some point in their lives. #16   A survey conducted for the National Institute on Drug Abuse found that more than 15 percent of all U.S. high school seniors abuse prescription drugs. #17   According to the CDC, approximately three quarters of a million people a year are rushed to emergency rooms in the United States because of adverse reactions to pharmaceutical drugs. #18   According to the Los Angeles Times, drug deaths (mostly caused by prescription drugs) are climbing at an astounding rate…. Drug fatalities more than doubled among teens and young adults between 2000 and 2008, years for which more detailed data are available. Deaths more than tripled among people aged 50 to 69, the Times analysis found. In terms of sheer numbers, the death toll is highest among people in their 40s. #19   In the United States today, prescription painkillers kill more Americans than heroin and cocaine combined. #20   Each year, tens of billions of dollars is spent on pharmaceutical marketing in the United States alone.  The American people deserve better than that. Every year, the United States spends more on health care than Japan, Germany, France, China, the U.K., Italy, Canada, Brazil, Spain and Australia combined. In fact, if the U.S. health care system was a separate nation it would be the 6th largest economy on the entire planet. For all the money that we spend, we should be the healthiest people in the world by a wide margin. Instead, life expectancy is higher in dozens of other countries and we have very high rates of cancer, heart disease and diabetes. For much more on the colossal failure of our health care system, please see my previous article entitled “50 Signs That The U.S. Health Care System Is A Gigantic Money Making Scam“. So what do you think about the pharmaceutical companies that are making billions of dollars by getting the American people addicted to their super-expensive legal drugs?      (Gigantic money-making scam!)     Michael Snyder  –  American Dream

Source:  e-mail sent from Drug Watch International  June 22 2013

Filed under: Economic,USA :

“Marijuana is perfectly safe” is one of the marijuana legalization movement’s most widely accepted (and most important) truisms.

 

Comical estimations of what would constitute a “lethal dose” — such as orally consuming more marijuana than the stomach can physically hold — lead to the also-accepted truism that it’s impossible to overdose on marijuana.

 

That may not be true.

 

With high-dosage edibles, it’s easy to become “uncomfortably high,” and with a recent trend called “dabbing,” it’s also easy to become so high that the user passes out. And passing out leads to the only recorded method of marijuana-related death.

“Dabbing” is a simple concept: a small amount of super-high concentrate — hash oil, wax, or another compound where so much of the marijuana plant’s plant material is removed that what’s left is between 50-to-80 percent active ingredients, a sort of grain alcohol to a bud’s wine — is put on a heated surface. A puff of smoke is emitted, and then the user inhales the entire puff of super-concentrated smoke.

 

The effects are immediate — and they’re intense. Folks who have used cannabis daily for 30 years report, “I am high again!” Other people not so used to the magic plant usually need to sit down for a minute or two before they can talk again. In other words, “dabbing” is a way to ingest a lot of medicine very quickly — and a way to get really f-d up.

 

It also may be dangerous, as California NORML’s Dale Gieringer writes in a recent letter to O’Shaughnessy’s, the marijuana medical journal published by veteran journalist Fred Gardner.

 

“In the past couple of years, there have been repeated occasions in which 911 teams have had to be called in due to cannabis overdoses,” Gieringer writes, going on to describe people passing out from high-concentrates at High Times Cannabis Cups in LA. The most authenticated record of someone dying from marijuana use, by the way? A man who became so incredibly high on hashish he passed out — and then died after hitting his head on a hard floor.

 

“Things like this never happened until the popularization of hash oil in recent years,” he adds. “The dangers are dire enough to merit a special warning.”

 

Most cannabis clubs in San Francisco don’t allow on-site consumption anymore — a by-product of newly opened dispensaries wishing to make a concession, any concession, in order to appease wary neighbors and win a permit, and also the federal Justice Department’s oddly selective crackdown, which shuttered popular smoking lounges at the Vapor Room and at HopeNet. But some that do also offer “dab bars” — where patients can have a couple mind-numbing, sense-paralyzing hits as a “thank you.”

 

This practice, while defensible for anyone who thinks marijuana prohibition should end, is hardly medical except for the sickest patients or those with the highest of tolerances. It also carries one more hidden danger — butane poisoning.

 

There are more concentrated forms of cannabis available on the market today than ever before — hashes, oils, waxes, a concoction called “budder,” glass, you name it. It’s surmised that a glut on the market led to this — there was too many flowers and too much bud than could be sold, and like many other commodities, a repacking or repurposing was necessary in order to find market value — and it’s also led to more of a dangerous chemical extraction process.

 

In order to separate the psychoactive components from the plant material, some kind of extraction process is required. A common process is ‘butane extraction.’  “When cannabis plant material is drenched in butane, its oils dissolve and can be captured in a container,” Dr. Jeffrey Hergenrather explains. “Instantaneously, the butane evaporates leaving only the oil behind.”

 

Sounds ok, but not only is this process illegal, it can also leave behind neurotoxins in your cannabis. If it smells like lighter fluid, don’t smoke it, Hergenrather writes — but it may not smell that bad, and still contain neurotoxins.

 

So dab away — but realize when you smoke yourself stupid, you may be literally doing so.

 

Source: http://blogs.sfweekly.com/thesnitch/ 2013/03/medical_marijuana_overdose_dabbing.php

Filed under: Marijuana and Medicine :

A group of former rough sleepers are being trained as outreach workers to help get homeless people off the streets. The Street Buddies project, run by housing and care provider Riverside English Churches Housing Group, began in January this year.

The group is being trained on issues such as substance use, mental health, professional boundaries and knowledge of the range of care services available. The scheme is being run in partnership with Westminster City Council and is being funded by the Homeless Transition Fund.

Last Wednesday Cllr Rachael Robathan, the council’s cabinet member for adult social care, congratulated the first group to go on the course and presented them with certificates at the Connection at St Martin’s-in-the Fields, Trafalgar Square.

Cllr Robathan said: “I’m very proud of this project and particularly proud to welcome you to the team of people working with us to help homeless people across the borough.

“As a group you have unique skills and your experience and the way you have turned your own lives around will, I hope, enable you to engage with many other rough sleepers and provide a powerful example of what can be achieved.”  One of the group to receive a certificate on Thursday was former rough sleeper Mariusz.

Mariusz began sleeping rough after his life spiralled out of control following the end of his marriage. He became addicted to drugs and stole to feed his habit. He said: “Because we’ve all been there ourselves. We know how to relate to people on the street. I really do want to connect with these people and tell them there is an alternative.” Natalie Lodge, Street Buddies coordinator, said: “This is a very exciting project that has the potential to change the way services are delivered in the future. We are using the expertise and knowledge that already exists on the street. Homeless people are part of the solution not the problem.”

Source: www.24dash.com Feb.2013

Filed under: Social Affairs :

This letter was recently  sent to US Attorney General Holder.  It contains a great deal of good  information about why the so-called ‘medical marijuana scam has resulted in increased use, and increased problems in the USA.

 

To: Hon. Eric Holder, US Attorney General and Michele M. Leonhart, Administrator of the Drug Enforcement Administration

From: David G. Evans, Executive Director of the Drug Free Schools Coalition

 

Dear Mr. Holder and Ms. Leonhart:

Parents across America are waiting for you to enforce the federal Controlled Substances Act in the states of Colorado and Washington, which have legalized recreational marijuana, as well as in the 19 states where “medical” marijuana is legal. These laws were passed as the result of a well-funded lobbying campaign by the marijuana industry. The public has been misled by this campaign to see marijuana as harmless, natural, and medicinal, just as we were misled years ago by the tobacco industry, which claimed that tobacco was not addictive and that smoking had no ill effects.

Anyone who is in the business of cultivating, selling, or distributing marijuana, including “medical” marijuana, is in violation of the federal Controlled Substances Act, which preempts state law. You must enforce federal law and begin prosecutions to stop the proliferation of “medical” marijuana stores and widespread recreational use of marijuana. I also urge you and President Obama to use the “bully pulpit” to make parents aware of the dangers of these pro-marijuana laws to our kids.

The damage of marijuana – and these laws – is clear. Legalization of marijuana for “medical” use and recreational use in those states has resulted in more marijuana use, particularly among young people, which can permanently impair brain development. Teens who use marijuana are more likely to engage in delinquent and dangerous behavior and experience increased risk of schizophrenia and depression. Despite arguments by the drug culture to the contrary, multiple studies show that marijuana is addictive. Marijuana is the number one drug causing young people to enter treatment and there has been a substantial increase in the people in treatment for marijuana dependence.

Marijuana use also damages the American economy. Employees who test positive for marijuana had 55 percent more industrial accidents and 85 percent more injuries, and they had absenteeism rates 75 percent higher than those who tested negative.

Medical marijuana

Science and experience say that passing “medical” marijuana legislation is bad medicine and poor policy. A past evaluation by several federal Department of Health and Human Services agencies, including the Food and Drug Administration, Substance Abuse and Mental Health Services Administration, and the National Institute for Drug Abuse, concluded that “no sound scientific studies supported medical use of marijuana for treatment in the United States, and no animal or human data supported the safety or efficacy of marijuana for general medical use.”

A major study, “Early Findings in Controlled Studies of Herbal Cannabis: A Review,” concluded that despite the widespread public interest in the therapeutic potential of herbal cannabis, “the data alone fails to make the case that crude, smoked cannabis should be made available to patients.” Numerous other studies have replicated those findings.

If marijuana is going to be considered a medicine, it should be treated as such and be subject to the Food and Drug Administration approval process that includes clinical trials to determine its efficacy as a medication.

Who is really using “medical” marijuana?

“Medical” marijuana is generally a ruse for recreational use of marijuana. Let’s look at two states with medical marijuana dispensaries – Colorado and California. Who is really getting “medical” marijuana in Colorado? As of December 31, 2012, there were 108,526 people getting “medical” marijuana. Of those, 94 percent are treating “pain,” and 16 percent are treating “muscle spasms.” These are very subjective determinations. Very few are getting it for serious conditions such as cancer (3 percent), glaucoma (1 percent), and HIV/AIDS (1 percent). The average age of cardholders is 41, and 68 percent are male; 37 “patients” are under the age of 18.

The Rocky Mountain High Intensity Drug Trafficking Area, which coordinates federal and state drug enforcement efforts in Colorado and nearby states, conducted a study to determine if Colorado’s “medical” marijuana is being diverted for unintended purposes. The report cites more than 70 public record examples of diversion by patients, caregivers, and dispensaries within Colorado and 23 different states. The assessment is just a sampling of what is suspected of being diverted. The Colorado program is not effective in stopping diversion.

A recent study examining California’s average “medical” marijuana patients found that the average “patient” was a 32-year-old white male with a history of drug and alcohol abuse and no history of a life-threatening disease.

Our children are being hurt

Mr. Holder, last month, during your testimony before the House Appropriations Committee, you were asked what factors would be weighed by the Department of Justice in deciding how to respond to the legalization of marijuana in Colorado and Washington. You stated that: “When it comes to these marijuana initiatives, I think among the kinds of things we will have to consider is the impact on children.”

It is time for you to act. Our kids are being hurt. A recent Colorado study surveyed kids from adolescent drug treatment programs in the Denver area and found that 73.8 percent of them reported using medical marijuana that had been recommended for someone else and was diverted to the kids.

A recent article from the Journal of the American Medical Association (JAMA) Pediatrics edition found that there is “a new appearance of unintentional marijuana ingestions by young children after modification of drug enforcement laws for marijuana possession in Colorado.”

A major study recently published by researchers at Columbia University in New York found that “medical” marijuana states have significantly higher rates of marijuana use and of marijuana abuse and dependence than states without such laws. In California, drugged driving is more prevalent than drunk driving nowadays.

“Medical” marijuana negatively affects public health especially in regard to our youth. Since the message that “marijuana is medicine” has been popularized, perceived harm from smoking marijuana among kids has steadily decreased.

America is violating international law

In addition to the harm being visited upon our children by recreational and medical” marijuana, your failure to adequately enforce federal law is also in violation of international law – the United Nations Single Convention on Narcotic Drugs of 1961, to which the United States is party. America has been warned by the International Narcotics Control Board about this violation. The UN can place sanctions on the US for violating the treaty. How could you let that happen?

To date, your enforcement has been spotty and only in a few states. Most of the marijuana states have seen no enforcement or even threats of enforcement by your office.

Please take action in Colorado and Washington and all the “medical” marijuana states. In many of the “medical” marijuana states, a simple letter from you that you were going to enforce federal law would have stopped “medical” marijuana laws from being passed or implemented.

Put our kids first and enforce the law.

Sincerely yours,

David G. Evans

Executive Director of the Drug Free Schools Coalition, Special advisor to the Drug Free America Foundation

Filed under: Legal Sector :

Purdue Pharma L.P. will present a poster describing the changes in abuse of OxyContin® and immediate-release oxycodone in rural Kentucky following the August 2010 introduction of reformulated OxyContin. This data is composed of follow-up interviews with a cohort of individuals in Kentucky who self-identified as original OxyContin abusers and will be presented at the College on Problems of Drug Dependence (CPDD) 75th Annual Meeting June 15 to 20 in San Diego.

Details of the scheduled poster presentation follows:

* Monday, June17, 8:00-10:00 a.m. PDT,  Poster No. 73

* “Abuse of OxyContin and immediate-release (IR) oxycodone in a rural Kentucky county following introduction of reformulated OxyContin – results from 6-month follow-up interviews” A. DeVeaugh-Geiss, C. Leukefeld, J. Havens, H. Kale, P. Coplan, H. Chilcoat

Study participants (individuals that reported abuse of original OxyContin prior to the reformulation) were initially interviewed about their drug use before and after the introduction of reformulated OxyContin, followed by six-month follow-up interviews.

Among the 164 participants who completed the 6-month follow-up interviews, 76 percent selected original OxyContin as their preferred drug prior to the reformulation.  In contrast, 66 percent of this population selected immediate-release oxycodone as their preferred drug after the reformulation; only one participant selected reformulated OxyContin as his or her preferred drug.

In follow-up interviews, 23 percent of participants reported attempting to manipulate the reformulated OxyContin for purposes of abuse.

From the initial interviews following the reformulation to the 6-month follow-up, the overall prevalence of original OxyContin abuse declined from 60 percent to 11 percent, and the overall frequency of abuse among those who abused declined from 11.3 days per month to 3.3 days per month.

During the same time period, prevalence of reformulated OxyContin abuse declined from 33 percent to 18 percent, while frequency among those who abused remained stable at 5.9 days per month vs. 5.7 days per month.

A decline in the prevalence of immediate-release oxycodone abuse, from 96 percent to 85 percent, also was observed during this time, while the frequency of abuse remained relatively constant.

Some abuse of OxyContin continued, and further research is necessary to determine whether similar effects are observed in other populations that abuse or misuse OxyContin.

The research was funded by Purdue Pharma L.P.

Source:  www.new.gnom.es   San Diego 17th June 2013

Urban Outfitters, a trendy shop selling mainly to young people was marketing merchandise made to look like prescription pill bottles including prescription label flasks, pint and shot glasses.  Drug prevention groups and parents flooded the company with complaints and they did withdraw these items. We need to be vigilant and make our voices heard whenever we see companies normalising or glamourising drug use.  Take up the phone or a pen and make a complaint !   NDPA

 

NEW YORK, June 17, 2013 /PRNewswire via COMTEX/ — The following is a Statement of Steve Pasierb, President and CEO, The Partnership at Drugfree.org:

Last Friday, Urban Outfitters issued a statement to CNN that it was halting the sale of prescription drug paraphernalia products. The statement read, “In this extensive range of product we recognize that from time to time there may be individual items that are misinterpreted by people who are not our customer. As a result of this misinterpretation we are electing to discontinue these few styles from our current product offering.”

On behalf of The Partnership at Drugfree.org, our partners and the families across the country affected by the issue of prescription drug misuse and abuse, we commend Urban Outfitters for doing the right thing by discontinuing the sale of these products from their current offerings.

This May, the California Friday Night Live Partnership alerted us that Urban Outfitters, a national retail store popular with teens, was selling merchandise made to look like prescription pill bottles including prescription label flasks, pint and shot glasses. In response, The Partnership at Drugfree.org launched an advocacy campaign and petition requesting that Urban Outfitters remove these products from their stores and website. Thanks to countless parents, teens, alliances and partners, including support from U.S. Representative Hal Rogers, Director of the Office of National Drug Control Policy Gil Kerlikowske, Kentucky Governor Steve Beshear and 22 State Attorneys General, our efforts secured more than 4,700 signatures of support on Causes.com.

Given that 90 percent of addictions start in the teenage years, these products, which linked medicine and alcohol and were aimed at a high school and college-age audience, wrongfully glorified the abuse and misuse of prescription drugs. All teenagers – regardless of who they are or where they live – are subject to the lure of drugs and alcohol. For this reason, The Partnership at Drugfree.org continues to focus its efforts on educating, motivating, supporting and empowering families with the resources they need to help protect children from drug and alcohol abuse, most specifically in conjunction with The Medicine Abuse Project, our national initiative to prevent half a million teens from abusing prescription drugs and over-the-counter cough medicine by 2017.

According to the CDC, prescription drug abuse in the United States is now at epidemic levels. More Americans die from prescription drug overdoses than from heroin and cocaine overdoses combined. And according to our recently released Partnership Attitude Tracking Study, teen prescription drug misuse and abuse is up by 33 percent since 2008.

Educating parents and our youth about the dangers of medicine abuse is an ongoing job; a job that we all as members of society must do together.

Source: www.marketwatch.com 17th June 2013

Filed under: Parents,USA :

As in Australia, an alcohol harm reduction curriculum adapted for secondary schools in Northern Ireland curbed the growth in alcohol-related problems and also meant pupils drank less. Results suggest this approach might offer a more fruitful focus for education about commonly used substances than simply promoting non-use.

Summary

Alcohol harm reduction approaches aim to decrease the harmful consequences of drinking without requiring abstinence. School-based substance use education programmes in the United Kingdom have mainly tried to delay the onset of use, though more recent programmes have included harm reduction components. Advantages of harm reduction approaches for adolescent pupils may include not stigmatising younger drinkers, not presenting drinking as a moral issue, and being able to tailor education to the specific risk factors of the particular pupil population. Such approaches seem most relevant at the ages when young people are first drinking unsupervised by adults and experiencing intoxication.

Developed and first evaluated in Australia, the School Health and Alcohol Harm Reduction Project (SHAHRP) is an example of harm reduction education, featuring skills training, information and activities designed to encourage behavioural change which reduces harms experienced as a result of drinking. Just such an effect was found in the original evaluation, in which the number of harms experienced by pupils in SHAHRP schools was substantially and significantly less than among pupils in schools not running the lessons, and remained so at the last follow-up 17 months after lessons had ended.

Given the prevalence of underage drinking in Northern Ireland and the associated problems, it was decided to adapt SHAHRP for Northern Irish secondary (or ‘high’) schools. As in the original study, the adapted version was delivered over two school years in two phases. The six lessons of phase one took place when pupils were in year 10 (age 13–14), and the four in phase two the following school year. A pilot study had found pupils and teachers felt the programme was easy to deliver, project materials helpful and easy to follow, and activities and discussions relevant and appropriate.

Having established its feasibility, to test the programme’s effectiveness a new study starting in 2005 recruited 29 secondary schools in the Belfast area. Nine carried on with the normal alcohol education curriculum (the control schools), the remainder also implemented SHAHRP. In eight SHAHRP schools it was delivered by the schools’ own teachers after being trained, in 12 by local voluntary-sector drug and alcohol educators. Rather than being assigned at random, schools were assigned to the three alcohol education options so that they would be comparable in terms of gender, socio-economic profile and location.

2349 pupils were surveyed at the start of the study; about 60% were girls, 17% had not drunk alcohol, and around half had already drunk without adult supervision. Surveys were repeated the following two years after the first and second phases of SHAHRP, and finally in March 2008 when lessons had ended at least 11 months before, at which time 2048 of the 2349 pupils (who now averaged 16½ year of age) could be re-surveyed. Though surveys were anonymous and confidential, identifiers could be used to track changes in each individual pupil across the three years.

Main findings

Generally the trends in how pupils drank and the harms they experienced were most favourable when SHAHRP lessons had been delivered by external specialists, next most favourable when they had delivered by the schools’ own teachers, and least favourable when SHAHRP had not been implemented at all. Selected more detailed findings below.

Each survey asked pupils who had drunk at some time during the study about any resulting harms over the past year, such as drinking more than they had planned, being sick after drinking, having hangover symptoms, being unable to remember what had happened while drunk, becoming verbally and/or physically abusive, and trouble with parents or police. Pupils divided in to four characteristic trajectories over the years of the study. Compared to those in control schools, pupils offered the SHAHRP lessons were more likely to have experienced virtually no harms during the study or a relatively low and stable level, rather than increasing and high levels of harm. When SHAHRP lessons had been delivered by external specialists, pupils were more likely to have experienced virtually no harms than when delivered by the schools’ own teachers. However, both types of SHAHRP delivery significantly improved on usual lessons only.

The drinkers among the pupils were also asked how much they had drunk last time. On this measure pupils again divided in to four characteristic trajectories. Compared to those in control schools, at each follow-up pupils offered the SHAHRP lessons were more likely say they had drunk very little than to have reported increasing and by the end of the study relatively high levels of drinking. When the lessons had been delivered by external specialists, pupils were more likely to consistently have drunk relatively little than when delivered by the schools’ own teachers.

Each survey also included questions about the harms pupils had experienced over the past year arising from someone else’s drinking, such as verbal or physical abuse, sexual harassment, or damage to personal property. Compared to those in control schools, pupils offered the SHAHRP lessons were least likely to have experienced a steep rise in such harms ending in relatively high levels. Whether SHAHRP lessons had been delivered by external specialists or the schools’ own teachers did not significantly affect the trends.

Pupils offered SHAHRP lessons were more likely than those in control schools to have become more knowledgeable about alcohol over the study and to end with relatively high levels of knowledge, more so when the lessons had been delivered by external specialists. However, both SHAHRP delivery options significantly improved on usual lessons only. Results were similar in respect of developing safer attitudes to drinking.

The authors’ conclusions A research review associated with guidance on alcohol education from the National Institute for Health and Clinical Excellence remarked that the Australian SHAHRP evaluation offered evidence that programmes focusing on harm reduction through skills-based activities can produce medium to long term reductions in alcohol use and in particular, risky drinking behaviours. However, the review queried the transferability of these programmes and their results to the UK. The featured study shows that in the UK too, classroom-based harm reduction education can have a significant impact on the harm adolescents experienced from

drinking. The research also suggests these lessons need to incorporate interactive learning, start just prior to and during the times when pupils first try drinking, be culturally sensitive, and provide realistic scenarios and deal with realistic issues.

Compared to control schools, pupils in SHAHRP schools were significantly more likely to be among groups characterised by better growth in knowledge about alcohol and its effects, safer alcohol-related attitudes, fewer harms from one’ own and other’s drinking, and less alcohol consumption. These differences were maintained over the 11 months after lessons had ended, though in some cases with diminished strength. External facilitation of the lessons was associated with the best outcomes, particularly with respect to knowledge and attitudes, harms from one’ own drinking, and alcohol consumption.

SHAHRP offers abstainers, novice drinkers and more experienced drinkers alike the opportunity to reflect on use, harm and personal safety, including the importance of trusted friends, basic first aid techniques, group transport home, mobile phone availability, not to make decisions while drunk, identify friends becoming drunk, drink-spiking, mixing substances, and arguments and aggressive behaviour. The results show that young people are capable of processing such messages developed and presented within the reality of their drinking experiences. SHAHRP addresses harms without causing any increase in drinking (in fact, the reverse) or decreasing rates of abstinence.

It was unfortunate that two of the schools allocated to the control group withdrew from the study, partially upsetting the attempt to ensure comparability of the schools operating the three alcohol education options. However, differences were adjusted for statistically. Also, no systematic record was kept on the alcohol education delivered to control subjects. In Northern Ireland this typically is embedded in the curriculum as part of science or citizenship lessons, so would be identical to that received by intervention students.

Together with the original Australian evaluation, this UK study represents fairly strong evidence that if it focuses on this task, a school curriculum can reduce drink-related problems. In Australia harm-reduction effects were greatest among the higher risk pupils who had already drunk without adult supervision; at each follow-up point they experienced about 20% fewer harms than control pupils.

In that study too, though still very much in the minority, by the last follow up there were a third more abstainers among SHAHRP than control pupils. By the end of the featured study about 6% of control pupils had never drank alcohol compared to 6% of SHAHRP pupils taught by external staff and 3.5% taught by their teachers. These findings offer little support to concerns that safer drinking lessons will encourage more pupils to drink.

In the featured study it seems SHAHRP lessons were additional to usual alcohol education, meaning that impacts might have been due to simply having more time devoted to this topic rather than or as well as the content. In Australia SHAHRP replaced usual alcohol education, thought there too it occupied two years rather than one and occupied more classroom time overall.

In the more restrictive youth drinking environment of the USA, a programme forefronting alcohol problem reduction among its aims has produced similar findings to that in Australia. It retarded growth in alcohol problems (such as getting drunk or sick or complaints from parents and friends), but only among pupils who had already drunk without adult supervision,

and only if the lessons did not occur too early to coincide with the development of this drinking pattern. After disappointing initial results, another US substance use education programme including alcohol adopted harm reduction objectives. The revised programme resulted in a significant reduction in risky or harmful drinking. Parallel and consistent findings in different countries with different curricula suggests that harm reduction education on drinking has a real and transferable impact in Western drinking cultures. Such findings contrast with unconvincing evidence from trials of substance use education in general and alcohol education in particular. For the UK the most important guidance on alcohol education was issued in 2007 by the National Institute for Health and Clinical Excellence. It said this “should aim to encourage children not to drink, delay the age at which young people start drinking and reduce the harm it can cause among those who do drink”. Recommendations included ensuring alcohol education is an integral part of the science and PSHE curricula. The committee stressed that education should be adapted to its cultural context, in particular that in the UK “alcohol use is considered normal for a large proportion of the population [and] a ‘harm reduction’ approach is favoured for young people”. Inspections in 2012 of PSHE lessons suggest English schools are far from adequately implementing NICE’s recommendations, in particular in respect of education aimed at reducing alcohol-related harm. In just under half the inspected schools had pupils learnt how to keep themselves safe in a variety of situations, and the deficits were particularly noticeable in respect of drinking. Inspectors found that although pupils understood the dangers to health of tobacco and illegal drugs, they were far less aware of the physical and social damage associated with risky drinking. Some did not know the strength of different alcoholic drinks or make the links between excessive drinking and issues such as heart and liver disease and personal safety. The report attributed these deficiencies in part to inadequacies in subject-specific training and support for PSHE teachers, particularly in teaching sensitive and controversial topics.

Last revised 18 June 2013. First uploaded 12 June 2013

Source: McKay M.T., McBride N.T., Sumnall H.R. et al.  Journal of Substance Use: 2012, 17(2), p. 98–121.

Espada J.P., Griffin K.W., Pereira J.R. et al.

Uniquely this Spanish study eliminated either problem solving or social skills training from secondary school drug education to see if these really were active ingredients in reducing substance use. Probably they were was the conclusion, though there were no statistically significant differences between the full programme and the excised versions.

Summary

Training in social skills and in problem-solving skills feature in many contemporary drug use prevention programmes. The former aims to promote assertiveness, empathy and social negotiation strategies, the latter, self-reliance and coping skills. Commonly these components are taught as generic skills first and then applied to situations related to substance use.

An example is the Spanish school programme Saluda which aims to delay the onset of alcohol and drug use. Its problem-solving components aim to help pupils understand and appreciate the advantages of non-consumption and the disadvantages of drug abuse by first applying problem-solving methods to everyday situations, and then specifically to substance use scenarios. The social skills components aim to help pupils develop skills related to active listening, initiating, maintaining and concluding conversations, expressing opinions and positive feelings, and defending one’s personal rights, such as saying ‘No’ and coping with peer pressure. Both types of components are taught mostly via skill-focused activities. Each is the focus of two different sessions of the 10-session programme, offering the opportunity to try variations which omit one but not the other as a way of testing which components are needed to generate the programme’s impacts. This was the strategy adopted by the featured study, which replaced the missing sessions with general discussion sessions not involving any skills training activities.

The study recruited 341 of the 358 students in 14 classes in two secondary schools. Whole classes were assigned to the full Saluda programme, to the programme with social skills but not problem solving training, to one with problem solving but not social skills training, or at random to education as usual until the final follow-up assessments had been completed a year after the Saluda lessons had finished.

Main findings

At the start of the study there were no statistically significant differences between pupils assigned to the different options. However, by the end questionnaires completed by the pupils revealed that those offered any version of Saluda had over the last month drunk alcohol significantly less often than pupils in education-as-usual classes. Though the biggest impact was seen with the full programme, there were no statistically significant differences between the three versions of Saluda. Similar findings emerged in respect to willingness to use alcohol or illegal drugs (actual use of the latter was too rare to be analysed), except that this pattern emerged in the surveys taken immediately after the lessons had ended as well as a year later.

The study also assessed the impact on the relevant skills of omitting lessons focused on these skills. In respect of problem solving skills, after the lessons ended both versions of the programme which had included the relevant training led to better skills (as assessed by a questionnaire) than among pupils not offered the programme at all, but this difference persisted to the final follow-up only after the full programme. In respect of social skills as reflected in reported difficulties with family, peers, or the opposite sex, on no measure were there any statistically significant differences between the three versions of the Saluda programme. Other findings revealed no obviously consistent pattern.

The authors’ conclusions

In general, findings indicated that the three versions of the Saluda programme were all significantly more effective at curbing drinking and intention to use substances than usual education only, but not significantly different from each other. However, there were indications that effectiveness may diminish unless training in both social and problem-solving skills is retained in the programme.

As assessed by average scores at the final follow-up, the largest advantages over usual education in drinking and in problem solving were seen after the full programme. In respect of problem solving, the full programme also bettered the version which included the relevant training, suggesting that social skills training acts synergistically with problem-solving training to improve problem-solving skills.

In terms of effects on skills, the programme without social skills training produced inconsistent changes in the relevant skills, as did the programme without problem solving skills training. It should be cautioned however that non-random assignment to the education options means the results may be due to differences between the pupils.

This draft entry is currently subject to consultation and correction by the study authors and other experts.

Source: Prevention Science: 2012, 13(1), p. 86–95.  June 2013.

 

Ageing festivalgoers still treat smoking weed as harmless fun. But its mind-destroying effects can no longer be denied  The festival season looms, mud and music for the wristbanded, tent-toting Glastobunnies, Latitudinarians and Bestivators. Sellers of falafels and fairy wings stock up, headliners and hopefuls load amps, and an MSN survey reveals that without children the average age of festivalgoers is now 35. The average! Even the BBC’s mass invasion of Glastonbury doesn’t explain that.

Of course many festivals are family outings, spawning happy tribal jokes about when Dad couldn’t find the tent after a 3am pee or Mum grumbled that the heavy-metal arena was drowning the verbose miserabilist in the Poetry Tent. Since the free, heady Sixties when my generation defied parental interdicts, festivals have become big business with £200 tickets, media villages and corporate VIP areas. And that’s fine. A British friend exiled in the upper echelons of Italian society mourned at Latitude that her new compatriots are just not “ludic” like us: too elegant to camp and romp and play.

But there’s a side to this romping that I hate. As one friend said, “It’s a moment to revive old habits”, the habit in question being cannabis. He knows that weed will be plentiful, and legal reprisals unlikely. Festival organisers piously warn against drugs but surging muddy crowds are hard to police. Last year the value of illegal substances seized at festivals saw a 75 per cent decline in confiscated cannabis while others, including Class A, rose. This suggests to me not so much a decline in festival spliffery (just stand downwind of one in the dusk) but an understandable reluctance by police to spend time snatching roll-ups from woozy middle-aged ravers who know that nothing worse than a warning or spot fine will result anyway.

So what’s the big deal, why mention it? It’s part of summer, innit, getting down with the kids and mellowing to the music. Why so sour, sister?

I wish I wasn’t, but it is only a few days since we heard that hospital admissions for mental disorders linked to cannabis use have risen by 50 per cent in three years. Psychiatrists warned for years that this could happen, estimating that people who smoked the newer strong stuff (now 80 per cent of the UK market) are many times more likely to suffer psychotic episodes. Youth runs the sharpest risk: a study of young Germans over a ten-year period found that those who started in their teens were nearly twice as likely to develop psychotic symptoms. Other factors (trauma, class, etc) were accounted for. In this country Professor Robin Murray of King’s College London says that even “use of traditional cannabis is a contributory cause of psychoses like schizophrenia”. An American study found that after cannabis became widely available in the US army in Europe, schizophrenia among troops increased 38-fold.

It needn’t even be the strong new stuff: it is fully forty years since Sir William Paton, professor of pharmacology at Oxford, found that even quite limited use could precipitate enduring hallucinations and fragmented paranoid thinking in people with no previous problems.   Let us be cautious and fair. There are more than 2 million users in Britain and most do not become psychotic. Either they don’t smoke enough, or they aren’t vulnerable. It is possible that people with a predisposition to mental torment are more likely to turn to cannabis for comfort anyway. And yes, alcohol is a vast problem too; so are harder drugs.   But slice it how you like, the evidence is ever stronger that young cannabis users not only risk what one study called “significant and irreversible” reduced IQ, but are playing Russian roulette with their mental health.

The criminal courts see cases of violence, including infanticide, linked by defence lawyers to a cannabis habit and resulting delusions. But the likelihood of self-harm is far greater. Which is why I get ever more sorrowful about the nonchalant normalisation of the drug,

and despise those who scoff at the evidence and shrug off their children’s and friends’ use in order to seem free-spirited: joking about being stoned, choonged, zoned, high.

I hate it because those who do suffer, suffer horribly. Patrick Cockburn, the eminent foreign correspondent, wrote movingly about (and with) his son Henry, who smoked joints heavily from the age of 14 and ended up with years of severe mental illness and near-death exploits of irrationality: swimming across a freezing river, climbing a railway viaduct. He would be found wandering naked, and spent years in institutions diagnosed as schizophrenic. Read Henry’s Demons. Then try to get the nearest pothead or stupid-cool parent to read it too.

Because, get this, my friends: psychosis is not fun. Really not. It is not some fabulous doors-of-perception experience from which creative minds return inspired. Some have been lucky with drugs and returned to fame and equilibrium. Lucky them. Others never come back but wander lost in a horrible world of threats and terrors, savage demons and shivering humiliations, cut off from love and health and fun and success and proper adventure. They are driven to the streets, the cells, to suicide. Yes, we all need risk: but the risk of madness is not an exhilarating one.

My sorrow over cannabis-cool has a personal dimension because my own son was a young suicide suffering (probably, from the evidence) from slowly advancing prodromal schizophrenia. It can happen spontaneously, or after physical illness, and so it did. Nicholas was never a drug user, recognising his fragility, and yet the tiger got him. So now I loathe seeing healthy kids deliberately strolling around in the tiger’s cage, assuming that it won’t ever wake up. And I despise adults who turn a blind eye or skin-up alongside their young at festivals, and fashionable role models who giggle irresponsibly about it in self-regarding articles and interviews. They are demons too.

As to the law, it could be that limited decriminalisation, Netherlands-style only more circumscribed, would serve better than our hypocritical semi-tolerance. I don’t know. But above all, just despise it. Bring on a culture of healthy social contempt, award cannabis its “tobacco moment” of declining status. My son, sailing with young Dutch shipmates, reported that they spoke of frequenters of cannabis cafés as pathetic: losers, unattractive wimps. Right on! If youth can’t laugh and relax without chemical assistance, it really is pathetic.

 

Source:   Libby Purves  http://www.thetimes.co.uk/tto/opinion/columnists/article3792586.ece June 17 2013 

Filed under: Social Affairs (Papers) :

“For first time, majority in U.S.  supports public smoking ban.” That was the headline in July 2011 as cigarette bans swept the country.  In 2000, just one major U.S.  city banned smoking at work sites, restaurants and bars.  As of last year, 60 percent of the 50 largest cities did, including Indianapolis.  Last July, Indiana became one of 38 states with smoke-free air laws.  “Majority now supports legalizing marijuana.” That headline appeared this spring amidst growing debate over liberalizing marijuana laws.  Although marijuana use is still against federal law, 26 states have legalized medical marijuana, decriminalized recreational marijuana or both.  Indiana has flirted with the idea.  Senate Bill 580 this past session would have made possession of less than two ounces of marijuana a Class C infraction punishable by nothing more than a fine — the same as a traffic ticket.  The bill died without a hearing; its author, Sen.  Karen Tallian, D-Portage, promised to reintroduce it next year.  A WISH-TV/Ball State University Hoosier Survey showed support for decriminalization at 53 percent.  What’s going on? The Hoosier Survey and poll results from Gallup and Pew Research Center suggest a severe case of schizophrenia on smoking.  Health advocates have succeeded in their marketing campaign against Big Tobacco but have failed to gain the upper hand in the marijuana debate.  This is partly due to misinformation and partly due to misrepresentation by activists.  The National Organization for the Reform of Marijuana Laws ( NORML ) is the most vocal group seeking to repeal marijuana restrictions.  The group says prominently on its website, “According to the prestigious European medical journal, The Lancet, ‘The smoking of cannabis, even long-term, is not harmful to health.’.”  Since The Lancet said those words in 1996, however, it has published numerous studies refuting the conclusion.  In 2009, it wrote, “Epidemiological, clinical and laboratory studies have established an association between cannabis use and adverse outcomes .   ( including ) dependence syndrome, increased risk of motor vehicle crashes, impaired respiratory function, cardiovascular disease, and adverse effects of regular use on adolescent psychosocial development and mental health.”  The typical cannabis cigarette “increases the smoker’s risk of developing lung cancer by 20 times the amount of one tobacco cigarette,” says the British Lung Foundation, which published a review of medical research in 2012.  Any smoking is bad for one’s health.  But on almost every measure, marijuana is more dangerous than tobacco, comparable with alcohol in its ability to impair judgment and to more-potent narcotics in its lasting effects on the brain. Marijuana harms short-term memory and makes it difficult to learn and retain information or perform complex tasks.  It slows reaction time and reduces motor coordination.  Prolonged use is “associated with lower test scores and lower educational attainment because during periods of intoxication the drug affects the ability to learn and process information, thus influencing attention, concentration and short-term memory,” said researchers M.  T. Lynskey and W.  D.  Hall.  One reason commonly given for decriminalizing marijuana is to free law enforcement to focus on serious crime and to reduce the number of minor possession cases clogging the court system.  The argument is naive.  The National Research Council has found that the long-term marijuana use can alter the nervous system in ways that promote violence.  Further, legalizing drugs doesn’t end illegal activity connected with drug trade.  Consider Amsterdam, where coffee houses selling marijuana are commonplace.  The city has been plagued by drug trafficking, drug tourism and street crime.  Support for legalizing marijuana has risen 11 points since 2010, an increase that can only be attributed to propaganda.  Policymakers must resist the urge to do the popular thing.  Society can’t deem cigarette smoking a public health hazard and simultaneously embrace marijuana smoking.

Source:  http://www.mapinc.org/media/1077   byAndrea Neal Indiana Policy Review Foundation.   14th June 2013 —

Filed under: Social Affairs :

Drug traffickers in the central city of Da Nang have switched their focus on methamphetamine and heroin from opium and marijuana over the last two years, a senior police officer told a press conference on drug prevention on Friday.

Lieutenant colonel Nguyen Xuan Cuong, Deputy Head of Counter Narcotics Office under the city’s Public Security Department, said the number of traffickers caught with methamphetamine in 2012 was seven times more than the amount in 2011.

Cuong added the city’s narcotics police force last year arrested a total of 128 drug offenders with 921.4 grams of methamphetamine, 54 grams of heroin and 133.6 grams of marijuana extracts.

A report at the conference shows there are an estimated 1,500 addicts and drug users at rehabilitation centers across the city.

Source: www.tuoitrenews.vn   16th June 2013

Abstract

Background

The present study assessed psychomotor function in chronic, daily cannabis smokers during 3 weeks continuously monitored abstinence on a secure research unit. We hypothesized that psychomotor performance would improve during abstinence of chronic, daily cannabis smokers.

Methodology/Principal Findings

Performance on the critical tracking (CTT) and divided attention (DAT) tasks was assessed in 19 male chronic, daily cannabis smokers at baseline and after 8, 14–16 and 21–23 days of continuously monitored abstinence. Psychomotor performance was compared to a control group of non-intoxicated occasional drug users. Critical frequency (?c) of the CTT and tracking error and control losses of the DAT were the primary outcome measures. Results showed that chronic cannabis smokers’ performance on the CTT (p<0.001) and the DAT (p<0.001) was impaired during baseline relative to the comparison group. Psychomotor performance in the chronic cannabis smokers improved over 3 weeks of abstinence, but did not recover to equivalent control group performance.

Conclusions/Significance

Sustained cannabis abstinence moderately improved critical tracking and divided attention performance in chronic, daily cannabis smokers, but impairment was still observable compared to controls after 3 weeks of abstinence. Between group differences, however, need to be interpreted with caution as chronic smokers and controls were not matched for education, social economic status, life style and race.

Source:   Wendy M. Bosker,  Erin L. Karschner  et al www.plosone.org      Jan.2013

The number of cannabis users suffering serious mental or behaviour disorders has increased by half in just four years.

The sharp rise has coincided with growing concerns over the increased prevalence of so-called “super skunk”, a particularly strong form of the drug.  In 2008, leading psychiatrists warned people who smoked super strength were 18 times more likely to suffer a psychotic episode.

Figures released to MPs show that the number of hospital admission for mental or behavioural issues due to cannabis rose from 651 in 2008/09 to 1,003 in 2011/12.

Mary Brett, who chairs the campaign group Cannabis Skunk Sense (CanSS), said: “’Despite many warnings over the years the rise in admissions must surely be truly alarming.

“However, this 54 per cent increase in episodes of cannabinoid-induced mental or behavioural issues should come as no surprise. Skunk, which accounts for about 80 per cent of the UK market has an average THC (a psychoactive ingredient) content of 16.2 per cent and ranges up to 46 per cent.

“Old fashioned 60 to 70s cannabis had around 1-2 per cent THC. “

In 2008, research by the Institute of Psychiatry at King’s College London suggested a direct link between skunk and the development of mental illness.  Scientists found that people who had a psychotic episode were twice as likely to have used cannabis for more than six years, three times more likely to have used it daily and 18 times more likely to use skunk.

Cannabis was reclassified as a Class B drug in 2009 some five years after being downgraded to Class C.

Source: Telegraph 15th June 2013

Russian President Vladimir Putin has signed a law introducing tests for students that will determine if they use drugs or psychotropic substances.

The federal law On Changes to Specific Legislative Acts of the Russian Federation on Issues Relating to the Prevention of Illegal (Non-Medical) Consumption of Drugs and Psychotropic Substances was passed by the State Duma on May 15 and approved by the Federation Council on May 29, the Kremlin reported on its website.

The document amends the legislation by introducing a system for early detection of the use by students of secondary and vocational schools of narcotic substances and psychotropic substances without a doctor’s prescription.

The law also outlines the powers of the federal and local authorities in the prevention of illegal drug consumption, including the powers to establish procedures and administer socio-psychological tests and preventive evaluations of students for early detection of drug abuse.

According to earlier reports, the law provides that teenagers younger than 15 will be tested with the consent of their parents and teenagers who are older than 15 can give their own consent to such tests.

The purpose of drug tests on students is to located risk groups and provide timely medical and psychological assistance.

Russian Deputy Education and Science Minister Alexander Klimov, who represented the bill at the State Duma meeting, said the socio-psychological evaluations will be conducted in the form of conversations and tests.

“Doctors will conduct these tests using modern technologies,” he said, pointing out that the results of the tests will be confidential by law. “It will be strictly controlled,” he said.

Source: www.rbth.ru   8th June 2013

Sir Richard Branson has called for the decriminalisation of drugs for recreational use.

Cannabis vending machines are being developed in US states where the drug has been legalised, while Sir Richard Branson has faced criticism after calling for decriminalisation here in the UK.    Virgin boss Sir Richard co-signed a letter with Caroline Lucas MP and others to The Times, calling for an “alternative drug strategy” and saying the current policy “pointlessly criminalises people”.

Cannabis was recently legalised for recreational use in Colorado and Washington, and three companies are currently developing vending machines for the drug in those states.

Criticise

Medical cannabis vending machines are already widely in use.

A group of drug experts, including Neil McKeganey of the Centre for Drug Misuse Research wrote to The Times criticising the call from Sir Richard and others.

The letter said: “There are now more medical marijuana outlets in some parts of the US than Starbucks cafés with cannabis-laced soft drinks and medical marijuana vending machines already much in evidence.

“Is this the alternative drug strategy that the signatories to the Times letter are seeking to promote?”

Dangers

The letter, also signed by the former head of the UN Office on Drugs and Crime and the president of ‘Europe Against Drugs’, warned about “grave dangers for humanity”.

It said: “We need a greater focus on abstinence-focused treatment, prevention, and robust enforcement and we need to strengthen, not weaken, the principle of shared responsibility between nations in how they are tackling their drug problem.”

“At a time when the use of illegal drugs in the UK is in decline we should be wary of those who claim that existing drug laws have failed.”

Decriminalise

Sir Richard Branson called on politicians to decriminalise drugs, saying they “would not lose votes”.

He made the comments ahead of an international drugs conference, at which he gave the opening address by video link.

Sir Richard, who is a member of the Global Commission on Drugs, said: “It has been proven in other countries that treating drug addiction as a health issue, not criminalising it, benefits society as a whole.”

Source: www.christian.org.uk  12th June 2013

The threat to public safety on the roadways posed by marijuana-impaired driving has been pushed to the top of nation’s agenda by the legalization of marijuana in Colorado and Washington as well as by the legalization of “medical” marijuana in 18 states and the District of Columbia. Marijuana has significant impairing psychological and physiological effects on driving. Marijuana use by drivers puts everyone at risk on our nation’s roadways; research shows that marijuana is a major cause of impaired driving and serious and fatal injury crashes.

To address marijuana-impaired driving, there has been an interest in identifying an impairment standard for marijuana that is the equivalent to the 0.08 g/dl Blood Alcohol Concentration (BAC) now used to prosecute alcohol-impaired drivers. Proposals have been put forward ranging from 2 ng/ml to 5 ng/ml tetrahydrocannabinol (THC) in whole blood. The science on this issue is clear: it is not possible to identify a valid impairment standard for marijuana or any other drug equivalent to the 0.08 g/dl limit for alcohol.

Alcohol is a poor model for studying the impairing effects of drugs because it is metabolized in simpler ways. Unlike alcohol, there is no close relationship between blood levels of drugs (or drug metabolites) and impairment. The vast number of impairing drugs and drug combinations often used with marijuana prevent any single measure from effectively covering all drivers. For example, a combination of low levels of alcohol and low levels of marijuana is severely impairing. Tolerance is another important factor preventing setting blood limits for marijuana and other drugs.  The Obama administration has strongly endorsed the implementation of drug    laws which specify that the presence of THC or marijuana metabolites (as well as other drugs) in a driver’s system is itself (i.e.“ per se”)   a criminal violation.   Zero tolerance laws use the limits of detection, the lowest concentration needed to reliably detect a drug.

Drastically different from zero tolerance, the marijuana legalization measure passed in 2012 in Washington State included a 5 ng/ml THC    limit for drivers age 21 and older. The 5 ng/ml  limit provides the appearance of protecting the public, but in reality it only protects marijuana users driving under the influence of marijuana from prosecution. Nearly all marijuana users test below 5 ng/ml of active THC in blood only a few hours after their last use.  A study of impaired drivers in Sweden with measurable THC in blood (>0.3 ng/ml) showed that 43% had THC concentrations less than 1 ng/ml; 61% had THC concentrations below 2 ng/ml 2  and over 90% of had THC levels under 5 ng/ml even though all of these drivers were judged to be impaired.

Because of the unavoidably long delay between arrest and blood collection, it is certain that THC concentrations were higher when these drivers were stopped for suspicion of drugged driving because of rapidly declining THC levels after marijuana use stops. THC concentrations were higher when drivers did not have other detected drugs in their blood “suggesting either more recent use or more frequent use of cannabis in these individuals.” Researchers concluded that the majority of drivers impaired by recent marijuana use would not be identified at cutoffs between 3 ng/ml and 5 ng/ml because THC is rapidly cleared from the blood after smoking marijuana. Therefore, under a 5 ng/ml THC  limit, only 10% of the drivers identified as impaired in this study would have been prosecuted.

Although Washington’s 5 ng/ml THC  limit is a poor policy for public safety, the law remains stronger than the 5 ng/ml THC permissible inference limit signed into law in Colorado after several previous failed attempts to pass      marijuana bills. While under the Washington law, a driver arrested for suspicion of drugged driving who tests at or above 5 ng/ml THC is in violation of the  law, in Colorado there is merely an inference that the same driver was under the influence when arrested and the driver can fight the charge in court. Given that over 70% of drivers in Colorado arrested for suspicion of driving under the influence of marijuana test below 5 ng/ml THC, these drivers are unlikely to be prosecuted at all.13 Moreover, the “permissible inference” will give almost all of the remaining 30% of arrested drivers a free pass to drive stoned. Underage drivers in Washington are subject to a zero tolerance      limit while in Colorado minors are subject to the same 5 ng/ml permissible inference limit as drivers age 21 and older.

Michigan uses the zero tolerance   standard for all Schedule I controlled substances, including marijuana; however, in May 2013, the Michigan Supreme Court ruled that “medical” marijuana users were not subject to the zero tolerance  standard for marijuana. In cases of drugged driving by an approved “medical” marijuana user, the state must prove the driver was impaired by marijuana at the time of arrest. This is similar to the way drivers impaired by

legally prescribed controlled drugs are treated in many states. In these states, drivers with valid prescriptions for controlled drugs can be prosecuted for drugged driving using the impairment standard. The prosecution of these drivers under the impairment standard is more challenging and less likely to be successful. The proliferation of drivers using “medical” marijuana has reignited calls for the development of a marijuana impairment standard.

The U.S. Department of Transportation (DOT) provides an important precedent for the use of the zero tolerance      standard.   DOT has successfully used this standard for nearly three decades for all safety-sensitive personnel including commercial drivers, airline pilots and train engineers. Any detected evidence of recent marijuana use is a violation because it is incompatible with the safe operation of vehicles. Either this standard is unwarranted for the people engaged in these safety-sensitive actions or it is the standard that should be applied to all motor vehicle drivers. The Institute for Behavior and Health, Inc. (IBH) strongly supports that the zero tolerance standard be applied to all drivers to protect the public safety on the nation’s roads and highways.

Advocates for permissive marijuana laws fear that the implementation of zero tolerance – or even in Colorado fear that 5 ng/ml – THC  drugged driving laws will translate to law enforcement officers targeting innocent marijuana users who will be wrongly prosecuted for impaired driving. Their concerns in part stem from a misunderstanding of the enforcement and drug and alcohol testing procedures related to driving under the influence (DUI). Individuals arrested for DUI have demonstrated behavioral impairment warranting their arrest before they are tested for alcohol or drugs. After arrest, these drivers now are tested for the presence of alcohol at the police station. If drivers produce a BAC of 0.08 g/dl (or higher), the testing procedure almost always stops. Typically only drivers arrested for impairment with low or zero BACs are tested for the presence of drugs. This means that only drivers who have already been arrested for being impaired will be drug tested.

Marijuana advocates also fear  drugged driving laws because of a misperception that most drivers testing positive for marijuana will not be impaired and will only test positive for marijuana (or its metabolites) because of use that occurred long before the arrest. As noted, drivers are tested for drugs only after they are arrested for DUI, or alternatively, if they are involved in serious or fatal crashes depending on the state procedures. No matter the circumstances under which drug testing of drivers takes place, the testing is unfortunately almost always long-delayed. Drug testing of DUI suspects typically is administered between 90 and 120 minutes after arrest while drug testing of injured drivers is done a few hours or longer after crashes.

Crucially important new research has shown that daily chronic marijuana users show observable deficits in driving skills as long as three weeks of abstinence compared to controls. It is possible that impairment was even longer lasting given that subjects were not tested after three weeks following their last use of marijuana. This is part of a large body of research that supports the use of the zero tolerance limit for marijuana.

Meta-analyses of epidemiological studies have concluded that smoking marijuana doubles risk of motor vehicle crash.   Studies of drivers involved in motor vehicle crashes support this conclusion. A study of seriously injured drivers admitted to a Maryland Level-1 shock trauma center showed that 26.9% of all seriously injured drivers tested positive for marijuana; half of drivers age 16 to 20 were positive for marijuana. A study of fatally injured drivers in Washington State showed 12.7% tested positive for marijuana and that among alcohol-positive drivers, 17.3% also tested positive for marijuana. The combination of marijuana use and alcohol is of great concern as evidence shows that low doses of marijuana combined with low doses of alcohol causes severe impairment. These data also show that combining alcohol and marijuana is common among seriously injured and fatally injured drivers.

Despite the evidence that marijuana use by drivers is a serious threat to public safety, there has been limited implementation and enforcement of drugged driving laws nationally, in part due to the widespread misperceptions actively spread by marijuana advocates who seek to limit any restrictions on drivers who use marijuana. Letting drivers arrested for DUI who test positive for marijuana walk away with no charge is a serious highway safety risk. New research conclusively demonstrates the folly of this approach.

Source:   www.ibhinc.org.   June 10th 2013

 

Growing numbers of cannabis users are needing hospital treatment for ‘mental disorders’ after smoking super-strength skunk, drugs campaigners warned last night.  In just three years, the number admitted for treatment has increased by 50 per cent – as the chemically enhanced danger drug has flooded the streets.

Last night drugs campaigners warned young people were severely damaging their mental health, and blamed permissive policing, including the use of cautions and spot fines.

Mary Brett, a trustee of Cannabis Skunk Sense said: ‘This worrying trend was entirely predictable, as a growing proportion of the cannabis on sale in Britain is now extremely potent skunk. This rising potency would seem to coincide with the numbers going into hospital, as more children are using this dangerous drug.We need an end to the authorities turning a blind eye to cannabis as if it is a harmless substance, as these figures show it clearly is not.’

Skunk sold on Britain’s streets is mostly grown in this country and is around five times as potent as traditional weed. Recent years have seen its prevalence surge compared to imported cannabis resin.  Figures released by the Department of Health show hospital admissions linked to cannabis use have increased by half in three years.

In 2008-9 some 651 admissions were recorded by the NHS in England relating to a diagnosis of ‘mental or behavioural disorder due to use of cannabinoids’. By 2011-12, that figure had risen to more than 1000.

The figures were released to shadow health minister Diane Abbott in response to a question lodged in Parliament. Last night Miss Abbott said: ‘These figures are really concerning.I think that too often, people are willing to romanticise cannabis. What we’re seeing on our streets is often skunk – many times more powerful than the cannabis which today’s ageing baby-boomers smoked in college.’

‘The government’s lack of focus and interest in this issue, and the way they have abolished the National Treatment Agency, means that many of these problems may get even worse. Evidence of the damage to mental health caused by cannabis use – from loss of concentration to paranoia, aggressiveness and outright psychosis – is mounting and cannot be ignored.’

Skunk sold on Britain’s streets is mostly grown in this country and is around five times as potent as traditional weed  A 2008 Home Office survey found average concentrations of THC – the active ingredient in cannabis – of 16 per cent.But in some samples the level was much higher – up to 45 per cent.   Skunk also contains less of an anti-psychotic ingredient which moderates the harmful effects of THC.

Repeated studies have shown the harmful impact on mental health of cannabis use among young people.  Research has suggested skunk users under 18 are four times more likely to suffer from schizophrenia in later life, and users under 15 may be ten times more likely than adults to suffer harmful effects.   Scientists also found long term use of skunk can lead to ‘significant and irreversible’ fall in a young person’s IQ.

Earlier this year, the Mail revealed chief police officers have quietly adopted a new ‘softer’ policy on illegal drug taking.  It means a ‘less robust enforcement approach’ on possession of drugs such as cannabis, with more offenders receiving spot fines.

Source: http://www.dailymail.co.uk/health/article-2340613/Mental-health-toll-skunk-cannabis-Number-users-admitted-hospital-smoking-drug-soars-50-years.html#ixzz2W7KEqf3b

Evaluating the pre and post treatment psychometric outcomes in an adult male category C prison.

Crane M.A.J., Blud L.  British Journal of Forensic Practice: 2012, 14(1), p.49–59..

From the early 2000s cognitive-behavioural group therapy programmes have been relied on to improve the anti-offending record of UK prisons and probation services, but evidence has been scarce and generally negative. This prison study at least suggests that one such programme does promote the intended psychological changes.

Summary Many British prisons offer the Prisoners Addressing Substance Related Offending (P-ASRO) programme, a cognitive-behavioural intervention intended to reduce crime by helping prisoners for whom this is a risk factor overcome their dependence on substance use. During 20 two-hour group sessions to be delivered over six weeks, the programme aims to enhance motivation to change, strengthen self-control, develop strategies to avoid relapse to problem substance use, and encourage lifestyle change to reduce the risk of a return to substance use and offending. It is intended for prisoners with a low to medium severity of dependence on substance use.

The featured study set out to test the impact of the programme on some of the psychological processes it targets as a means of reducing substance use and crime. It used data collected anonymously from 81 male inmates in a prison in England who had completed the P-ASRO programme, the only one run by the prison to address substance use problems. They completed psychological assessment questionnaires before starting the programme and after completing it. Before the programme a standard questionnaire assessed their severity of dependence; 74 of the 81 prisoners scored as highly dependent and seven as low to medium, meaning that most would have been considered too highly dependent to be suitable for the programme.

Main findings

The study reported changes from before to after the P-ASRO programme in assessments of: Locus of control

The extent to which individuals believe that they can control events that affect them.

Impulsiveness: The tendency to act without planning and on the spur of the moment and to be unable to sustain focus on the task in hand.

Social problem solving: An individual’s problem-solving strengths and weaknesses; whether they approach problems positively and rationally.

Stage of change: An assessment of whether in relation to a particular issue (in this case, substance use) someone is not yet contemplating change, considering it, taking action, or maintaining the changes they have made.

On all four measures the prisoners had substantially improved. There were statistically significant improvements in the degree to which they felt in control of their lives and in their approaches to problem solving, and a reduction in the tendency to behave impulsively. Before the programme just 25% of the prisoners were taking steps to change their substance use habits, but afterwards 86% were doing so, generally having progressed from merely contemplating change. In no case was the degree of improvement related to how severely dependent the prisoner had been before the programme started.

The authors’ conclusions

The findings of this study indicate that the P-ASRO programme may have a positive impact on key areas such as problem solving and self-control likely to affect pro-social behaviour change, and that it does so regardless of how severely dependent the prisoner was before the programme. After the programme, completers also were also more motivated to take action to change their substance patterns.

Improvement on the locus of control measure suggests the prisoners developed a greater sense of self-efficacy and belief in their ability to change, found in studies to be predictive of behaviour changes which minimise the risk of relapse. Impulsivity improvements suggests the offenders became more reflective in their thoughts and related actions, so possibly less likely to revert to drug use and more likely to consider the long-term consequences of their substance use. More positive problem-solving attitudes and better skills should enable offenders generate more pro-social solutions to problems and generally improve their problem-solving abilities. The stage of change assessments suggest that the P-ASRO programme may have motivated participants to take action towards achieving a lifestyle free of problem substance use.

However, the study could not assess whether these changes in the psychological processes presumed to generate substance use and crime actually did lead to longer term reduction in drug-related offending, nor whether users of different substances or polydrug users responded more or less well to the programme. Neither was there a control group of similar prisoners who did not go through the programme against which to benchmark the observed changes, and there was no way to adjust the results for factors which might have affected them such as the prisoner’s age or risk of reconviction. Also, a few prisoners who did not complete the programme were excluded from the sample. Had they been included, average degrees of improvement might have been lower.

The results of this study are reassuring because they suggest that the P-ASRO programme does not have counterproductive impacts. When like-minded people are brought together there is a risk that the group will reinforce the features they share, in this case, a tendency to criminogenic substance use. Regarding positive impacts, as the authors point out, it is impossible to say whether the changes they observed would have happened anyway, even without the programme, and whether they will translate in to less crime and substance use on release. On this score studies of similar programmes, and in Britain of the equivalent programme for offenders on probation, have not been promising ( below). However, the situation in prison is very different from that outside; in its favour, it seems many more prisoners than probationers complete the programmes, giving them a chance to have an impact, but motivation gained in prison is often of little consequence once the offender is released.

P-ASRO is based on the ASRO programme for offenders serving community sentences outside prison, results from which have not been promising. In its 2008–2011 national drug strategy for offenders, the National Offender Management Service referred to research showing that re-offending rates fall by almost 7% for offenders placed on ASRO-type anti-offending programmes. This may refer to an unpublished Home Office evaluation not specific to the ASRO or P-ASRO programmes and which lacked a comparison group. Instead it compared predicted reconviction rates for offenders referred to programmes like ASRO with their actual convictions. The results appeared generally positive. Compared to a predicted rate of 61%, just 55% of all offenders were reconvicted within two years, while the reconviction rate for those completing a programme was 38% compared with a predicted rate of 51%. Though in the ‘right’ direction, the design of the research means its results cannot be relied on as indicating that the programmes reduced offending.

Set against this possibly positive finding are several studies which produced negative findings. Among these is British study which found that even the minority of offenders who completed an ASRO programme were no less likely to be reconvicted within the following year than similar comparison offenders. When from year 2000, ASRO-type cognitive programmes for offenders were being rolled out in Britain, an evaluation of their impact on offenders on probation found no reduction in reconviction rates compared to offenders not placed on these programmes. There was, however, the familiar low level of reconviction among the minority who had completed the programmes, an effect which might have been due to factors which would have improved their prospects regardless of the programme, such as their motivation to change, ability to do so, and their stability. Among these programmes was the prototype ASRO, trialled on 62 offenders of whom 21% had completed it. Results from the ASRO paralleled those of the cognitive programmes in general. More generally, a review of studies which had randomly allocated offenders in or out of prison to anti-offending programmes found two which had evaluated ASRO-type cognitive skills approaches. These created no statistically significant gains on measures indicative of drug use or crime. Even when in a controlled study a cognitive programme has been found effective, this has not necessarily been maintained in a larger scale roll-out. In British prisons in the 1990s, early cognitive skills programmes aimed generally at tackling criminogenic attitudes and thought patterns at first evaluated positively but later the results were not replicated. Interventions for offenders are, it has been argued, highly context-specific; what works in one culture at one time may be ineffective in other settings and at other times.

P-ASRO and ASRO are among the programmes accredited by the Correctional Services Accreditation Panel for England and Wales. The panel’s report for 2010–2011 notes that both will be replaced by a new programme, Building Skills for Recovery. By the last quarter of 2011–12, 21 prisons in England and Wales were running the new programme while 29 still offered P-ASRO. However, in 2010–2011 the dominant programme was neither of these but one intended for prisoners serving short sentences, on remand, or with just six months left to serve, also it seems to be replaced by Building Skills for Recovery.

In theory the panel required evaluation evidence before selecting programmes to accredit, but in practice this was rarely available within the time scale required to meet government implementation targets. Instead it usually accredited programmes on the basis that they embodied the general principles of ‘what works’, which (largely on the basis of North American evidence) meant cognitive-behavioural methods, of which ASRO is an example. Evidence on programmes as implemented in the UK derived largely from studies not capable of determining impacts on offending.

Thanks for their comments on this entry in draft to Mark Crane of HM Prison Service, Wolverhampton, England, one of the authors of the featured study. Commentators bear no responsibility for the text including the interpretations and any remaining errors.

Last revised 06 June 2013. First uploaded 03 June 2013

<em>Source:  www.findings.org.uk reporting on British Journal of Forensic Practice

Filed under: Crime/Violence/Prison :

He’s less than two weeks old, but he shows the telltale signs of a baby agitated and in pain: an open sore on his chin where he’s rubbed the skin raw, along with a scratch on his left check. He suffers from so many tremors that he’s been placed in a special area so nurses can watch him around the clock in case he starts seizing —or worse, stops breathing.  The baby is one of many infants born dependent on drugs. He is being treated at East Tennessee Children’s Hospital in Knoxville, where doctors and nurses are on the front lines fighting the nation’s prescription drug epidemic. Drug abuse in the state is ranked among the nation’s highest, according to some estimates, a fact underscored by the number of  babies born with signs of drug dependence. In 2008, East Tennessee Children’s Hospital treated 33 infants at the hospital for drug dependence, known as neonatal abstinence syndrome. Officials there expect that number to skyrocket to 320 this year. Since 2008, the hospital has treated 538 infants who are dependent on drugs. Last year, the hospital treated 283 babies suffering from dependence.  “It blew us away,” Andrew Pressnell, a nurse at the unit, said of the dramatic increase. “We didn’t know what to do.”  In most cases at the hospital, which specializes in treating drug-dependent infants and has shared its methods with other facilities nationwide, mothers had abused prescription painkillers or anti-anxiety medicines while pregnant, including hydrocodone, oxycodone, Xanax and Valium.  States across the U.S. have passed laws to crack down on prescription drug abuse, including in the Appalachian region, where the drugs were easily available as they flowed north from so-called “pill mills” in Florida. Federal authorities have stepped up prosecutions, and states including Kentucky and West Virginia have passed laws in an effort to curb the problem. Tennessee also is working swiftly to get a hold of the crisis, through both new laws and education about the dangers of abusing drugs while pregnant. It also is believed to be the first state to require all health care facilities to report every instance of a baby born dependent on drugs, according to Tennessee Health Department officials. The federal government doesn’t track the number of babies born dependent on drugs. And until now, the state could provide only estimates because testing for drugs in a baby’s system can’t always tell whether the infant suffers from dependence.  The state estimates that nearly 1,200 drug-dependent babies have been born in Tennessee in 2010 and 2011, the last two years where data is available. State Health Department records show that drug-dependent Babies were hospitalised 55 times in 1999, a figure that increased to 672 in 2011. Compounding that is the fact that the most recent data shows only Alabama and Oklahoma have higher rates of narcotic use, according to Express Scripts, the nation’s largest pharmacy benefits manager. The figures nationally are equally sobering: A study published last year in the Journal of the American Medical Association found that more than 13,000 infants were affected

across the U.S. in 2009. Tennessee is the first state to track the number of babies born dependent on prescription drugs, said Stephen W. Patrick, a neonatologist at the University of Michigan and one of the authors of the study. “It’s important for us to understand in as near real time as we can the scope of this epidemic as it relates to babies born dependent on addictive drugs,” Tennessee Department of Health Commissioner John Dreyzehner said. Dreyzehner, a medical doctor who practiced both occupational and addiction medicine, ordered all medical centers in the state to report every case of drug-dependent newborns. The prescription drug epidemic that is sweeping the country began in Appalachia, Dreyzehner said, and Tennessee is in crisis because significant portions of the state are in that region. But other states, he said, are now starting to see problems with the babies as the pill epidemic moves outside its epicenters.  Officials have been estimating based on discharge data that showed symptoms that babies suffered while in a hospital. Now they’re going to get real-time data to see how widespread the problem really is in the state. Part of the solution is better education—the health commissioner is part of a group lobbying the Food and Drug Administration to put a warning on prescription drug bottles of the dangers of taking drugs while pregnant. The preferred way to treat drug-dependent babies at the Knoxville hospital is by giving them small doses of an opiate and gradually weaning them off, said Dr. John Buchheit, who heads the neonatology unit at East Tennessee Children’s. So every few hours, the staff will give the infants morphine to help them get their symptoms of withdrawal under control. They’ll be weaned off over a period of either days or weeks, Buchheit said. However, there is little research showing the best ways to treat such infants, or how they may be affected long-term. On average, infants stay at the hospital for about four weeks’ time because they have to be watched so closely.  “The problem is the side effects of morphine,” Buchheit said. “The one we worry about—the biggie—is that it can cause you to stop breathing.” All that extra care adds up. Figures from TennCare, Tennessee’s Medicaid Program, show that it costs on average $62,973 to treat a baby with NAS compared with $7,763 for the care of an infant who is not dependent.  The influx of cases forced the hospital to develop its own set of protocols for treating infants, and those have been shared with other hospitals nationwide, Buchheit said. “They have a well-oiled machine,” said Patrick, one of the authors of the national study, said of the Knoxville hospital unit.   And it has to be: Roughly half of the neonatal unit’s 49 infants are being treated for drug dependence. For those infants, the pain can be excruciating. The doctors and nurses who treat them say the babies can suffer from nausea, vomiting, severe stomach cramps and diarrhea. “Diarrhea so bad that their bottoms will turn red like somebody has dipped them in scalding water and blistered and bled,” said Carla Saunders, a neonatal nurse practitioner who helps coordinate the treatment at the children’s hospital. They have trouble eating, sleeping and in the worst cases suffer from seizures. Many suffer from skin conditions and tremors. Nurses place mittens on their hands because

the babies get so agitated that they constantly scratch and rub their faces. And they are inconsolable. A small army of volunteers called “cuddlers” help the staff by holding the infants, rocking them and helping them ride out their symptoms.   Many of the babies have private, dark rooms with high-tech rocking machines to keep them calm. Bob Woodruff, one of the 57 cuddlers the hospital relies on, gently rocks Liam, a 10-day old infant who was born drug-dependent. Liam sleeps soundly in the 71-year-old retired University of Tennessee professor’s arms. Woodruff moves from room to room, wherever he’s needed. He’ll swaddle the babies tightly, walk with them if it seems to settle them down or just let them feel a loving touch.   Woodruff, a grandfather who said he loves babies, wanted to do some volunteer work after he retired. “It’s very satisfying,” he said. “A big reason why I do it is because I believe it’s helping the babies.” It is impossible to be unmoved by these infants, said Saunders, the neonatal nurse practitioner.  “If there is anything that could drive the people in our society to stop turning their heads to adult addiction,” she said, “it’s going to be the babies.”

Source:  www.santacruzsentinel.com  5th June 2013

Filed under: Social Affairs,USA :

Anti-drug advocates who have admonished for years that marijuana is a “gateway drug” may be on to something, says a study by Yale University School of Medicine researchers, reports Connecticut Post. The state director of the National Organization for the Reform of Marijuana Laws dismissed the findings as “just another propaganda study.” The Yale study, which appears online in the Journal of Adolescent Health, showed that alcohol, cigarettes, and marijuana were associated with an increased likelihood of prescription drug abuse in men 18 to 25. In women of that age, only marijuana use was linked with a higher likelihood of prescription drug abuse.

For years, researchers have looked at a connection between marijuana and hard drugs, such as cocaine and heroin, said Lynn Fiellin, the study’s lead author and an associate professor of medicine at Yale. “I don’t think the general population has a good idea of how serious the problem is with prescription opioids,” Fiellin said. “When they’re abused or misused, these are hard drugs.” Researchers focused on a sample of 55,215 18- to 25-year-olds. Of those, 6,496, about 12 percent, reported that they were abusing prescription opioids. Of the group abusing these drugs, about 57 percent had used alcohol, 56 percent had smoked cigarettes and 34 percent had used marijuana.

Source:  www.thecrimereport.org   3rd June 2013

Anyone who has ever walked into a “non-smoking” hotel room and caught the distinct odor of cigarette smoke will not be surprised by the findings of a new study: When a hotel allows smoking in any of its rooms, the smoke gets into all of its rooms, the study suggests.

Nicotine residues and other chemical traces “don’t stay in the smoking rooms,” says Georg Matt, a psychologist from San Diego State University who led the study, published Monday in the journal Tobacco Control. “They end up in the hallways and in other rooms, including non-smoking rooms.”

The study found smoke residue on surfaces and in the air of both smoking and non-smoking rooms in 30 California hotels where smoking was allowed. Levels were highest in the smoking rooms, but levels in non-smoking rooms were much higher than those found at 10 smoke-free hotels.

Volunteers who stayed overnight in the smoking hotels also ended up with sticky nicotine residues on their fingers, whether they stayed in smoking rooms or not. Urine tests found additional evidence of nicotine exposure in those who stayed in smoking rooms, but not those who stayed in the non-smoking rooms.

The research comes as smoke-free hotels are becoming more common, though not as common as smoke-free bars and restaurants. Many large chains, including Marriott, Westin and Comfort Inn, have gone smoke-free and hotels must be smoke-free by law in four states and 71 cities and counties, according to the Americans for Nonsmokers’ Rights Foundation. Nearly two-thirds of hotels responding to a recent survey by the American Hotel & Lodging Association said they were smoke-free, though just 39% of economy hotels said so.

The reason many hotels still offer smoking rooms is that some domestic and international travelers still want them, says Kathryn Potter, senior vice president of marketing and communications for the hotel association, based in Washington, D.C. “I have family members (and) friends who book hotels based on where they can smoke,” Potter says.

About one in five U.S. adults still smoke, according to the federal Centers for Disease Control and Prevention (CDC).  Matt says his study suggests non-smokers should choose only hotels with no smoking. He says it’s likely that non-smoking guests are routinely exposed to second-hand smoke seeping under doorways and moving through ventilation systems as people smoke elsewhere in hotels. Yet the study also shows widespread contamination with what researchers call “third-hand smoke,” the pollutants left behind on furniture, drapes, carpets and in the air, long after cigarettes are extinguished.

Matt says it is possible people are sneaking cigarettes in some of the smoke-free rooms, but other research shows second- and third-hand smoke can travel through homes and apartment buildings.

Second-hand smoke is linked with health effects, including asthma attacks, heart disease and lung cancer, according to the CDC. The effects of third-hand smoke are not as clear.

“We do know third-hand smoke contains many of the same toxins we find in second-hand smoke,” Matt says. “When the smoke disappears, the danger does not end.”

Source: USA TODAY   May 13, 2013

Filed under: Health,Nicotine,USA :

China needs to put more effort into teaching young people not to use drugs, rather than just strengthening programs to help drug abusers, experts say.

Prevention and treatment is not keeping up with drug use trends in Asia, said Chris Chapleo, scientific & clinical affairs director, at the first conference of national youth substance abuse in China, an event organized by the China Association of Drug Abuse Prevention and Treatment.

Statistics show that students in renowned middle and high schools are less accessible to drug dealers, thanks to the education campaign promoted by the government.

Wang Zengzhen, professor at Tongji Medical University, said more attention to and emotional intervention in pilot training programs have proved to be more efficient that doing nothing in the schooling system.

Recent years have seen an increasing number of young drug addicts in China using both traditional substances and newly invented ones. “It is not only the problems of young addicts, but their families,” said Zhao Min, vice president of Shanghai Mental Health Center.

Meanwhile, young people in Guangdong province, Fujian province and other regions of the country prefer cough syrup containing codeine and ephedrine, both of which are addictive substances.

“The youngsters store the cough syrup and condense the medicine to extract the drug they need,” said He Rihui, director of the youth addict treatment center at Wu Jing Zong Dui Hospital of Guangdong Province.

Eighty-seven percent of cough syrup addicts said they began substance abuse between the ages of 12 and 18. And because of the adverse effects on their health, 69 percent of cough syrup abusers are unable to work and stay at home.

“More professional staff are needed so that measurements can be more useful than they were in previous period of treatment and prevention,” said Shi Jianchun, deputy director of the Association of Drug Abuse Education in Beijing.

Source:  chinadaily.com.cn   2013-05-23

Parents make a difference in their kids abusing pot, alcohol, drugs

A recent SAMHSA study confirms that kids are many times less likely to use drugs when they know that their parents would disapprove of that behavior.

Put another way, in terms of marijuana use alone, kids are 6 times more likely to use pot simply because of a parental attitude of indifference towards marijuana use.

Given the huge difference in outcomes, is there any other drug education program that can achieve this kind of result? Of course not. Parents are on the front lines of prevention and need to understand that their attitudes about drug use are a key factor in decisions made by their children.

I am often approached by concerned parents who are desperately seeking the solution to keeping their kids drug-free in a drug-filled world. The answer is always the same: love your kids enough to take a strong stand against drug use, communicate your values consistently and regularly to your children, surround your children with other caring adults and youth who possess similar values, and live the way you teach.

Does parental involvement guarantee that a child will not be influenced by a culture that is awash in drug propaganda? No, but it will give that child the best chance for a drug-free life.

ROCKVILLE, Md., May 26 (UPI) — More than 1-in-5 parents say they have little influence in preventing teens from using illicit substances, but surveys prove them wrong, a U.S. agency says.

A report by the Substance Abuse and Mental Health Services Administration found 22 percent of U.S parents of children ages 12-17 said they had little influence on whether or not their child uses illicit substances, tobacco or alcohol.

The annual survey involved 67,500 Americans age 12 or older.

Pamela S. Hyde, administrator of SAMHSA, said national surveys of youths 12-17 show those who believe their parents would strongly disapprove of their substance use were less likely to use substances. For example, 5 percent of current marijuana users said their parents would strongly disapprove of their trying marijuana once or twice versus 31.5 percent of current marijuana who did not perceive this level of parental disapproval.

“Surveys of teens repeatedly show that parents can make an enormous difference in influencing their children’s perceptions of tobacco, alcohol, or illicit drug use,” Hyde said in a statement. “Although most parents are talking with their teens about the risks of tobacco, alcohol and other drugs, far too many are missing the vital opportunity these conversations provide in influencing their children’s health and well-being. Parents need to initiate age-appropriate conversations about these issues with their children at all stages of their development in order to help ensure that their children make the right decisions.”

 

<em>Source: http://www.upi.com/Health_News/2013/05/26/Parents-key-to-preventing-substance-abuse-in-their-children/UPI-82251369611312/ </em>

Filed under: Parents :

California voters passed the country’s first medical-marijuana law in 1996, but many are having second thoughts. Last year, five California cities voted on initiatives to allow marijuana dispensaries, and all five voted no. Oregon also voted down dispensaries. These liberal West Coast states have seen medical marijuana up close, and learned it’s barely medical at all.

That shouldn’t surprise anyone. The idea that smoking pot is medicine didn’t come from doctors or groups representing the seriously ill. Neither the American Cancer Society nor the National Multiple Sclerosis Society supports it, and the American Medical Association and American Academy of Pediatrics strongly oppose it.

The idea to call marijuana medicine came from the National Organization for the Reform of Marijuana Laws and the Marijuana Policy Project. These two organizations are part of a national marijuana lobby that represents drug users, growers and sellers. They’re behind every medical-marijuana law in the country.

They advertise these laws with an impassioned plea to allow suffering, terminally ill people access to medicine. However, once these laws pass, most medical-marijuana patients claim pain, not serious illness. In Arizona, 90 percent get their marijuana for pain. In Colorado and Oregon, it’s 94 percent. Pain is every drug addict’s favorite complaint; it’s easy to fake and impossible to disprove.

Good doctors try to screen out drug abusers, but medical-marijuana laws are designed to circumvent good medical care. Most marijuana patients get their prescriptions from a few unethical doctors who see patients one time only and hand out marijuana recommendations to anyone.

Pot-smokers know who these doctors are, and they line their waiting rooms. Before Montana tightened its law, eight doctors wrote three-fourths of all the recommendations. In Arizona, 24 doctors did the same.

That’s why there’s a backlash. People feel hoodwinked. They voted for compassionate care, not drug abuse.

I’m a partisan Democrat who supports most liberal causes, but I’m also an addiction psychiatrist. I work with drug abusers. They’re amazing con artists who will say anything to get their drugs. And the marijuana lobby is no different.

For example, based on scant evidence, advocates claimed for years that marijuana could treat glaucoma. Today, ophthalmologists believe marijuana can damage the optic nerve and make glaucoma worse. The Glaucoma Foundation now warns patients not to use the drug, yet no marijuana advocate has ever apologized for handing out bad medical advice.

The pot lobby paints the Drug Enforcement Agency and the Food and Drug Administration as blue meanies, depriving people of needed medicine. But science consistently proves these agencies right. For every illness possibly helped by marijuana, there are safer and more effective medications already available. There aren’t thousands of people suffering because they can’t use pot; that’s a fiction the marijuana lobby invented.

In Arizona, they actually called their campaign “Stop Arresting Patients.” They wanted us to picture grannies in prison, doing their knitting surrounded by tattooed gang-bangers. But in a live debate, the Marijuana Policy Project lobbyist could not name even one genuine medical patient who’d been arrested solely for possession. That’s because there aren’t any. Medical-marijuana laws protect drug dealers and drug users, not the seriously ill.

Even worse, these laws hurt innocent people. An analysis of several studies, published in the British Medical Journal, found that drivers under the influence of marijuana had nearly twice as many serious and fatal car wrecks as nonusers. California, Colorado and Montana all documented increased traffic fatalities caused by drivers with marijuana components in their bloodstreams, coinciding with increased use of medical marijuana.

The biggest damage, however, is done to our kids. The National Survey of Drug Use and Health shows that teenage marijuana use is 30 percent higher in medical-marijuana states. Teens who smoke pot do worse in school, do worse in their adult careers and have twice the school drop-out rate of nonsmokers. No parent wants that.

Last, these laws cost states money. The marijuana lobby promises that taxes on pot will fill state coffers, but it’s just another deception. States with these laws pay out of their general funds to regulate marijuana, and for the increased health care, substance-abuse treatment and law enforcement needed any time an addictive drug becomes more available.

So don’t be taken in; medical marijuana is a ruse. It’s bad medicine that helps hardly anyone and has serious social and economic side effects for all.

Dr. Ed Gogek is an addiction psychiatrist in Prescott, Ariz., and board member of Keep AZ Drug Free, a group that opposes legalization and medical-marijuana laws.

Source:  http://www.dispatch.com/content/stories/editorials/2013/05/23/voters-becoming-wise-to-medical-marijuana-ruse.html

Filed under: Legal Sector,USA :

Converging evidence suggests cannabis is addictive for many and harmful to adolescents and to those at risk for mental illness. About 9 percent of people who use cannabis become addicted. The younger one starts, the greater the risk of addiction. Cannabis withdrawal includes craving, trouble sleeping, poor appetite, anxiety, malaise, tension and depressed mood that impairs daily functioning and predicts relapse to cannabis use. The cannabis withdrawal syndrome has been compared to that of nicotine, which is of undoubted clinical significance. Nicotine is very addictive. Compared with nicotine, marijuana is probably less addictive, but more harmful to brain function, particularly young brains – and recent data indicate that marijuana use may increase the addictiveness of nicotine. Regular cannabis use has been associated with an 8- to 10-point drop in I.Q. over the course of 20 years, a change that would bring one from the 50th percentile to just over the 30th. Again, those who started regular use in adolescence experienced greater I.Q. decline than those who started as adults. Marijuana worsens cognitive performance, particularly in the domains of verbal learning, verbal working memory and attention accuracy. Some deficits appear to be lasting. Attention accuracy deficits associated with cannabis use do not improve with abstinence. These results suggest hippocampal, subcortical and prefrontal cortex abnormalities, some of which may be lasting. Brain white matter connectivity is adversely affected to a greater extent in those who begin regular cannabis use in early adolescence. Animal studies also show neuroplastic changes in areas of the brain associated with addiction, like the nucleus accumbens. Cannabis use increases the risk for schizophrenia in people who have underlying genetic risk, and early age at first use is associated with earlier age at onset of psychosis. Two common gene variants have been identified that, combined with cannabis use, increase the risk for psychosis. A minority of those who use cannabis develop psychosis, but we are currently unable to predict who is at risk. So increasing use, which legalization is bound to do, will increase the numbers of those at risk who are exposed and harmed.

Cannabis is potentially addictive and harmful to the brain, especially in adolescents. As a society, we are going in the wrong direction on marijuana.

The public must be educated that cannabis is both potentially addictive and harmful to the brain, with a greater effect on the most vulnerable among us, kids. Where it has been legalized, its use has increased, particularly among young people who are at greatest risk from exposure. This trend of legalization will be difficult to reverse, even as we learn more about the harmful effects of regular cannabis use at early ages.

Another factor to consider is that the marijuana available today is more potent than ever. THC levels have been rising while cannabidiol levels, protective for anxiety and

psychosis, have been decreasing. Recent increases in hospital admissions for cannabis dependence treatment correlate with potency and with legalization.

Thus legalization increases availability, increases use, increases dependence and increases harm, particularly to vulnerable groups like adolescents and those already at risk for mental illness. As a society, we are going in the wrong direction on marijuana. Eden Evins, an associate professor of psychiatry at Harvard Medical School, is the director of the Center for Addiction Medicine at the Massachusetts General Hospital. John Kelly, Luke Stoeckel, Jodi Gilman, Gladys Pachas and Brandon Bergman contributed to this article.

Source: http://www.nytimes.com/roomfordebate/2013/05/22/how-can-marijuana-be-sold-safely/marijuana-is-a-risky-habit-we-shouldnt-encourage

Filed under: Social Affairs :

Marijuana has been gaining public acceptance as a medicinal treatment and as a “lifestyle choice” in states where its use has been decriminalized or legalized. But long-term users need to know about a possible side effect that is extremely distressing. Called cannabinoid hyperemesis, it is characterized by repeated episodes of nausea, vomiting and colicky abdominal pain.

Doctors generally are unaware of this problem, so they don’t ask about a history of pot smoking when someone comes for help. Patients themselves don’t connect their discomfort to marijuana—and in fact, some smoke even more, thinking that pot will ease their nausea (as it does for chemotherapy patients).

Tracking the problem: A recent study from Scripps Green Hospital and Clinic in San Diego reported on adult cannabinoid hyperemesis patients with severe cyclic nausea, abdominal pain and intractable vomiting. Most had started smoking marijuana in their teens and currently were daily users. Each had undergone numerous diagnostic tests, including laboratory analyses, abdominal ultrasounds, CT scans and/or endoscopies…had gone to the emergency room an average of six times…and had been hospitalized three times, on average, at an estimated cost per patient of nearly $30,000!

Cannabinoid hyperemesis can affect users of synthetic cannabis (colloquially known as Spice) as well as “natural” marijuana users. Interestingly, hot baths or showers may provide temporary relief—a factoid that can help doctors and patients recognize the problem.

Medicinal marijuana users: If you use marijuana medicinally—for instance, to ease rheumatoid arthritis, Crohn’s disease, glaucoma, multiple sclerosis or the side effects of cancer treatment—be on the lookout for possible symptoms of cannabinoid hyperemesis. If you experience recurrent nausea and vomiting, talk to your doctor about other treatment options that don’t have this distressing side effect.

Recreational smokers: The only known way to halt cannabinoid hyperemesis for good is to stop smoking pot, a tactic that works for 80% of patients. So before you spend countless hours and thousands of dollars looking for a diagnosis and treatment, quit using marijuana and see whether your nausea, vomiting and abdominal pain abate. Can’t quit on your own? Narcotics Anonymous (NA), a 12-step program patterned after Alcoholics Anonymous, can help. Or for more information call 818-773-9999.

Source: Daily Health News May 9, 2013

Case reports from Scripps Green Hospital and Clinic, San Diego, presented at a recent meeting of the American College of Gastroenterology.

 

In the last several months, my colleagues and I have noticed rising levels of THC in the urine of our young patients — but the average increase I present here surprised even us.

THC, which is short for tetrahydrocannabinol, is the active ingredient in marijuana that gives users a high and is chiefly responsible for making the drug addictive (yes, it’s addictive; responsible and respected scientists no longer debate this). In the last 40 years, growers have worked steadily to spike THC levels in marijuana — taking a page from the playbook of Big Tobacco, which was caught spiking nicotine and adding chemicals to make cigarettes more addictive.

Marijuana’s THC levels have increased substantially in the last 40 years. In the 1960s and ’70s, marijuana’s THC levels averaged around 2 percent. Today, they easily exceed 10 percent. In medical marijuana states, including Colorado, where I live, potent strains frequently falling into adolescents’ hands top 40 percent THC.  Then there’s the concentrated form of THC, commonly called hash oil, that is extracted from the plant and added to foods and drinks and inhaled through smokeless vaporizers. THC concentrate can exceed 90 percent.

At the same time THC has risen, so has adolescent marijuana use. Consider this from the University of Michigan’s Monitoring the Future Survey:

* In 1991, 8 percent of the nation’s high school students reported past-month marijuana use. The past-month use rate reported last year was 15.5 percent.

* In 1991, 0.9 percent of the nation’s high school students reported daily use. Last year it was 3.5 percent.

With all of this top of mind, my colleagues and I examined the results of approximately 5,000 urinalyses of adolescents treated in a downtown Denver clinic where I practice. The patients were ages 13 to 19.

As you’ll see in the chart below, from 2007 through 2009, the average rate was 358 nanograms per milliliter of urine. This time period immediately preceded the opening of hundreds of marijuana dispensaries in Colorado.

From 2010 through February 2013, the average THC rate registered at 536 nanograms per milliliter of urine. This time period coincides with a boom in access to, and social acceptance of, marijuana in Colorado, where voters in November 2012 approved a constitutional amendment legalizing the drug for recreational use.

Why should we care about this rise in THC rates? What do they mean? Here are some preliminary thoughts as I continue my research:

* Young people are using marijuana more frequently, or they’re using more potent marijuana, or they’re using more potent marijuana more frequently. I suspect the third option is most likely.

* When young people report for treatment, their marijuana addiction is more serious. It takes longer to treat them and requires more resources to do so — which means their treatment is more costly.

* Typically, the more severe the addiction, the poorer the prognosis for recovery.

* I am increasingly concerned about concentrated THC, which is infused into an ever-growing number of edible products and pushed to users in other smokeless forms that are billed as safer and healthier to use because they don’t involve smoking. My colleagues and I also have found that these smokeless forms of ingesting THC are increasingly popular with young people who are eager to hide their drug use.

It is reasonable now to question how much longer it will be before we see injection use of THC — especially as marijuana is legalized.

 

Source:  www.drthurstone.com   9th May 2013

Filed under: Cannabis/Marijuana,Youth :

“For first time, majority in U.S.  supports public smoking ban.” That was the headline in July 2011 as cigarette bans swept the country.  In 2000, just one major U.S.  city banned smoking at work sites, restaurants and bars.  As of last year, 60 percent of the 50 largest cities did, including Indianapolis.  Last July, Indiana became one of 38 states with smoke-free air laws.  “Majority now supports legalizing marijuana.” That headline appeared this spring amidst growing debate over liberalizing marijuana laws.  Although marijuana use is still against federal law, 26 states have legalized medical marijuana, decriminalized recreational marijuana or both.  Indiana has flirted with the idea.  Senate Bill 580 this past session would have made possession of less than two ounces of marijuana a Class C infraction punishable by nothing more than a fine — the same as a traffic ticket.  The bill died without a hearing; its author, Sen.  Karen Tallian, D-Portage, promised to reintroduce it next year.  A WISH-TV/Ball State University Hoosier Survey showed support for decriminalization at 53 percent.  What’s going on? The Hoosier Survey and poll results from Gallup and Pew Research Center suggest a severe case of schizophrenia on smoking.  Health advocates have succeeded in their marketing campaign against Big Tobacco but have failed to gain the upper hand in the marijuana debate.  This is partly due to misinformation and partly due to misrepresentation by activists.  The National Organization for the Reform of Marijuana Laws ( NORML ) is the most vocal group seeking to repeal marijuana restrictions.  The group says prominently on its website, “According to the prestigious European medical journal, The Lancet, ‘The smoking of cannabis, even long-term, is not harmful to health.’.”  Since The Lancet said those words in 1996, however, it has published numerous studies refuting the conclusion.  In 2009, it wrote, “Epidemiological, clinical and laboratory studies have established an association between cannabis use and adverse outcomes .   ( including ) dependence syndrome, increased risk of motor vehicle crashes, impaired respiratory function, cardiovascular disease, and adverse effects of regular use on adolescent psychosocial development and mental health.”  The typical cannabis cigarette “increases the smoker’s risk of developing lung cancer by 20 times the amount of one tobacco cigarette,” says the British Lung Foundation, which published a review of medical research in 2012.  Any smoking is bad for one’s health.  But on almost every measure, marijuana is more dangerous than tobacco, comparable with alcohol in its ability to impair judgment and to more-potent narcotics in its lasting effects on the brain. Marijuana harms short-term memory and makes it difficult to learn and retain information or perform complex tasks.  It slows reaction time and reduces motor coordination.  Prolonged use is “associated with lower test scores and lower educational attainment because during periods of intoxication the drug affects the ability to learn and process information, thus influencing attention, concentration and short-term memory,” said researchers M.  T. Lynskey and W.  D.  Hall.  One reason commonly given for decriminalizing marijuana is to free law enforcement to focus on serious crime and to reduce the number of minor possession cases clogging the court system.  The argument is naive.  The National Research Council has found that the long-term marijuana use can alter the nervous system in ways that promote violence.  Further, legalizing drugs doesn’t end illegal activity connected with drug trade.  Consider Amsterdam, where coffee houses selling marijuana are commonplace.  The city has been plagued by drug trafficking, drug tourism and street crime.  Support for legalizing marijuana has risen 11 points since 2010, an increase that can only be attributed to propaganda.  Policymakers must resist the urge to do the popular thing.  Society can’t deem cigarette smoking a public health hazard and simultaneously embrace marijuana smoking.

Source:  http://www.mapinc.org/media/1077   byAndrea Neal Indiana Policy Review Foundation.   14th June 2013

Back to top of page

Powered by WordPress